Medtronic plc G5960L103 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"); Craig Arnold DIRECTOR ELECTIONS ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"); Scott C. Donnelly DIRECTOR ELECTIONS ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"); Lidia L. Fonseca DIRECTOR ELECTIONS ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"); John P. Groetelaars DIRECTOR ELECTIONS ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"); Randall J. Hogan, III DIRECTOR ELECTIONS ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"); William R. Jellison DIRECTOR ELECTIONS ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"); Joon S. Lee, M.D. DIRECTOR ELECTIONS ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"); Gregory P. Lewis DIRECTOR ELECTIONS ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"); Kevin E. Lofton DIRECTOR ELECTIONS ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"); Geoffrey S. MarthaArnold DIRECTOR ELECTIONS ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"); Elizabeth G. Nabel, M.D. DIRECTOR ELECTIONS ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"); Kendall J. Powell DIRECTOR ELECTIONS ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2026 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration AUDIT-RELATED ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Approving, on an advisory basis, the Company's executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Approving, on an advisory basis, the Company's executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR 1 S000002922 Medtronic plc G5960L103 10/16/2025 Renewing the Board of Directors' authority to issue shares under Irish law CAPITAL STRUCTURE ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law CAPITAL STRUCTURE ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares CAPITAL STRUCTURE ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Approving an amendment to Article 17 of the Company's Articles of Association, to facilitate the capitalization of certain of the Company's non-distributable reserves CAPITAL STRUCTURE ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Approving a Capital Reduction to Create Distributable Reserves under Irish Law; and CAPITAL STRUCTURE ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Medtronic plc G5960L103 10/16/2025 Approving amendments to the Company's Articles of Association, to update the advance notice provisions. CORPORATE GOVERNANCE ISSUER 5618365.000000 0.000000 FOR 5618365.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/17/2025 2025 H Share Incentive Scheme and the Scheme Mandate Limit COMPENSATION ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/17/2025 Allocation of Interim Dividends CAPITAL STRUCTURE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/17/2025 Elect MENG Hong DIRECTOR ELECTIONS ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/17/2025 First Batch Proposed Amendments to Articles CORPORATE GOVERNANCE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/17/2025 Second Batch Proposed Amendments to Articles CORPORATE GOVERNANCE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 10/17/2025 Third Batch Proposed Amendments to Articles CORPORATE GOVERNANCE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Bio-Techne Corporation 09073M104 10/30/2025 To set the number of Directors at nine. CORPORATE GOVERNANCE ISSUER 2044160.000000 0.000000 FOR 2044160.000000 FOR S000002922 Bio-Techne Corporation 09073M104 10/30/2025 Election of Directors: Robert V. Baumgartner DIRECTOR ELECTIONS ISSUER 2044160.000000 0.000000 FOR 2044160.000000 FOR S000002922 Bio-Techne Corporation 09073M104 10/30/2025 Election of Directors: Julie L. Bushman DIRECTOR ELECTIONS ISSUER 2044160.000000 0.000000 FOR 2044160.000000 FOR S000002922 Bio-Techne Corporation 09073M104 10/30/2025 Election of Directors: Judith Klimovsky DIRECTOR ELECTIONS ISSUER 2044160.000000 0.000000 FOR 2044160.000000 FOR S000002922 Bio-Techne Corporation 09073M104 10/30/2025 Election of Directors: John L. Higgins DIRECTOR ELECTIONS ISSUER 2044160.000000 0.000000 FOR 2044160.000000 FOR S000002922 Bio-Techne Corporation 09073M104 10/30/2025 Election of Directors: Kim Kelderman DIRECTOR ELECTIONS ISSUER 2044160.000000 0.000000 FOR 2044160.000000 FOR S000002922 Bio-Techne Corporation 09073M104 10/30/2025 Election of Directors: Alpna Seth DIRECTOR ELECTIONS ISSUER 2044160.000000 0.000000 FOR 2044160.000000 FOR S000002922 Bio-Techne Corporation 09073M104 10/30/2025 Election of Directors: Rupert Vessey DIRECTOR ELECTIONS ISSUER 2044160.000000 0.000000 FOR 2044160.000000 FOR S000002922 Bio-Techne Corporation 09073M104 10/30/2025 Election of Directors: Joseph D. Keegan DIRECTOR ELECTIONS ISSUER 2044160.000000 0.000000 FOR 2044160.000000 FOR S000002922 Bio-Techne Corporation 09073M104 10/30/2025 Election of Directors: Amy Herr DIRECTOR ELECTIONS ISSUER 2044160.000000 0.000000 FOR 2044160.000000 FOR S000002922 Bio-Techne Corporation 09073M104 10/30/2025 Approve, on an advisory basis, the compensation of our executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2044160.000000 0.000000 FOR 2044160.000000 FOR S000002922 Bio-Techne Corporation 09073M104 10/30/2025 Approve, on an advisory basis, the compensation of our executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2044160.000000 0.000000 FOR 2044160.000000 FOR 1 S000002922 Bio-Techne Corporation 09073M104 10/30/2025 Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 2044160.000000 0.000000 FOR 2044160.000000 FOR S000002922 AstraZeneca plc GB0009895292 11/03/2025 Adoption of New Articles CORPORATE GOVERNANCE ISSUER 13113119.000000 0.000000 FOR 13113119.000000 FOR S000002922 Cardinal Health, Inc. 14149Y108 11/05/2025 Election of Directors: Robert W. Azelby DIRECTOR ELECTIONS ISSUER 1053326.000000 0.000000 FOR 1053326.000000 FOR S000002922 Cardinal Health, Inc. 14149Y108 11/05/2025 Election of Directors: Michelle M. Brennan DIRECTOR ELECTIONS ISSUER 1053326.000000 0.000000 FOR 1053326.000000 FOR S000002922 Cardinal Health, Inc. 14149Y108 11/05/2025 Election of Directors: Sheri H. Edison DIRECTOR ELECTIONS ISSUER 1053326.000000 0.000000 FOR 1053326.000000 FOR S000002922 Cardinal Health, Inc. 14149Y108 11/05/2025 Election of Directors: David C. Evans DIRECTOR ELECTIONS ISSUER 1053326.000000 0.000000 FOR 1053326.000000 FOR S000002922 Cardinal Health, Inc. 14149Y108 11/05/2025 Election of Directors: Patricia A. Hemingway Hall DIRECTOR ELECTIONS ISSUER 1053326.000000 0.000000 FOR 1053326.000000 FOR S000002922 Cardinal Health, Inc. 14149Y108 11/05/2025 Election of Directors: Jason M. Hollar DIRECTOR ELECTIONS ISSUER 1053326.000000 0.000000 FOR 1053326.000000 FOR S000002922 Cardinal Health, Inc. 14149Y108 11/05/2025 Election of Directors: Akhil Johri DIRECTOR ELECTIONS ISSUER 1053326.000000 0.000000 FOR 1053326.000000 FOR S000002922 Cardinal Health, Inc. 14149Y108 11/05/2025 Election of Directors: Gregory B. Kenny DIRECTOR ELECTIONS ISSUER 1053326.000000 0.000000 FOR 1053326.000000 FOR S000002922 Cardinal Health, Inc. 14149Y108 11/05/2025 Election of Directors: Nancy Killefer DIRECTOR ELECTIONS ISSUER 1053326.000000 0.000000 FOR 1053326.000000 FOR S000002922 Cardinal Health, Inc. 14149Y108 11/05/2025 Election of Directors: Christine A. Mundkur DIRECTOR ELECTIONS ISSUER 1053326.000000 0.000000 FOR 1053326.000000 FOR S000002922 Cardinal Health, Inc. 14149Y108 11/05/2025 Election of Directors: Robert W. Musslewhite DIRECTOR ELECTIONS ISSUER 1053326.000000 0.000000 FOR 1053326.000000 FOR S000002922 Cardinal Health, Inc. 14149Y108 11/05/2025 Election of Directors: Sudhakar Ramakrishna DIRECTOR ELECTIONS ISSUER 1053326.000000 0.000000 FOR 1053326.000000 FOR S000002922 Cardinal Health, Inc. 14149Y108 11/05/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1053326.000000 0.000000 FOR 1053326.000000 FOR S000002922 Cardinal Health, Inc. 14149Y108 11/05/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1053326.000000 0.000000 FOR 1053326.000000 FOR 1 S000002922 Cardinal Health, Inc. 14149Y108 11/05/2025 To ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2026 AUDIT-RELATED ISSUER 1053326.000000 0.000000 FOR 1053326.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 11/14/2025 Shareholder Proposal Regarding Election of Lars Rebien Sorensen as Chair DIRECTOR ELECTIONS SECURITY HOLDER 4927319.000000 0.000000 ABSTAIN 4927319.000000 AGAINST S000002922 Novo Nordisk A/S DK0062498333 11/14/2025 Shareholder Proposal Regarding Election of Cornelis de Jong as Vice Chair DIRECTOR ELECTIONS SECURITY HOLDER 4927319.000000 0.000000 ABSTAIN 4927319.000000 AGAINST S000002922 Novo Nordisk A/S DK0062498333 11/14/2025 Shareholder Proposal Regarding Election of Britt Meelby Jensen DIRECTOR ELECTIONS SECURITY HOLDER 4927319.000000 0.000000 ABSTAIN 4927319.000000 AGAINST S000002922 Novo Nordisk A/S DK0062498333 11/14/2025 Shareholder Proposal Regarding Election of Mikael Dolsten DIRECTOR ELECTIONS SECURITY HOLDER 4927319.000000 0.000000 ABSTAIN 4927319.000000 AGAINST S000002922 Novo Nordisk A/S DK0062498333 11/14/2025 Shareholder Proposal Regarding Election of Stephan Engels DIRECTOR ELECTIONS SECURITY HOLDER 4927319.000000 0.000000 ABSTAIN 4927319.000000 AGAINST S000002922 argenx SE NL0010832176 11/18/2025 Remuneration Policy COMPENSATION ISSUER 470860.000000 0.000000 FOR 470860.000000 FOR S000002922 argenx SE NL0010832176 11/18/2025 Remuneration Policy COMPENSATION ISSUER 830306.000000 0.000000 FOR 830306.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 12/19/2025 Purchase Framework Agreement EXTRAORDINARY TRANSACTIONS ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 12/19/2025 Logistic Support Services Framework EXTRAORDINARY TRANSACTIONS ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 12/19/2025 Elect LI Qiang DIRECTOR ELECTIONS ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 12/19/2025 Change in Company Type CORPORATE GOVERNANCE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 12/30/2025 Approval of the 2025 Share Scheme COMPENSATION ISSUER 2250277.000000 0.000000 FOR 2250277.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 12/30/2025 Approve Scheme Mandate Limit COMPENSATION ISSUER 2250277.000000 0.000000 FOR 2250277.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 12/30/2025 Approve Service Provider Sublimit COMPENSATION ISSUER 2250277.000000 0.000000 FOR 2250277.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 12/31/2025 Amendments to Articles CORPORATE GOVERNANCE ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 02/09/2026 Adoption of the H Share Option Scheme COMPENSATION ISSUER 1979400.000000 0.000000 FOR 1979400.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 02/09/2026 Adoption of the H Share Incentive Scheme COMPENSATION ISSUER 1979400.000000 0.000000 FOR 1979400.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 02/09/2026 Approval of the Scheme Limit COMPENSATION ISSUER 1979400.000000 0.000000 FOR 1979400.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 02/09/2026 Approval of the Service Provider Sublimit COMPENSATION ISSUER 1979400.000000 0.000000 FOR 1979400.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 02/09/2026 Board Authorization to Handle Matters Pertaining to the H Share Option Scheme and H Share Incentive Scheme CORPORATE GOVERNANCE ISSUER 1979400.000000 0.000000 FOR 1979400.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 02/09/2026 Authority to Repurchase H Shares CAPITAL STRUCTURE ISSUER 1979400.000000 0.000000 FOR 1979400.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 02/09/2026 Amendments to Articles and Abolishment of the Supervisory Committee CORPORATE GOVERNANCE ISSUER 1979400.000000 0.000000 FOR 1979400.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 02/12/2026 Sale and Purchase Agreement, Compensation Agreement and Letter of Non-Competition Undertakings EXTRAORDINARY TRANSACTIONS ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Cencora, Inc. 03073E105 03/05/2026 Election of Directors: Werner Baumann DIRECTOR ELECTIONS ISSUER 2863084.000000 0.000000 FOR 2863084.000000 FOR S000002922 Cencora, Inc. 03073E105 03/05/2026 Election of Directors: Frank K. Clyburn DIRECTOR ELECTIONS ISSUER 2863084.000000 0.000000 FOR 2863084.000000 FOR S000002922 Cencora, Inc. 03073E105 03/05/2026 Election of Directors: Ellen G. Cooper DIRECTOR ELECTIONS ISSUER 2863084.000000 0.000000 FOR 2863084.000000 FOR S000002922 Cencora, Inc. 03073E105 03/05/2026 Election of Directors: D. Mark Durcan DIRECTOR ELECTIONS ISSUER 2863084.000000 0.000000 FOR 2863084.000000 FOR S000002922 Cencora, Inc. 03073E105 03/05/2026 Election of Directors: Lon R. Greenberg DIRECTOR ELECTIONS ISSUER 2863084.000000 0.000000 FOR 2863084.000000 FOR S000002922 Cencora, Inc. 03073E105 03/05/2026 Election of Directors: Lorence H. Kim, M.D. DIRECTOR ELECTIONS ISSUER 2863084.000000 0.000000 FOR 2863084.000000 FOR S000002922 Cencora, Inc. 03073E105 03/05/2026 Election of Directors: Robert P. Mauch DIRECTOR ELECTIONS ISSUER 2863084.000000 0.000000 FOR 2863084.000000 FOR S000002922 Cencora, Inc. 03073E105 03/05/2026 Election of Directors: Redonda G. Miller, M.D. DIRECTOR ELECTIONS ISSUER 2863084.000000 0.000000 FOR 2863084.000000 FOR S000002922 Cencora, Inc. 03073E105 03/05/2026 Election of Directors: Dennis M. Nally DIRECTOR ELECTIONS ISSUER 2863084.000000 0.000000 FOR 2863084.000000 FOR S000002922 Cencora, Inc. 03073E105 03/05/2026 Election of Directors: Lori J. Ryerkerk DIRECTOR ELECTIONS ISSUER 2863084.000000 0.000000 FOR 2863084.000000 FOR S000002922 Cencora, Inc. 03073E105 03/05/2026 Election of Directors: Lauren M. Tyler DIRECTOR ELECTIONS ISSUER 2863084.000000 0.000000 FOR 2863084.000000 FOR S000002922 Cencora, Inc. 03073E105 03/05/2026 Advisory vote to approve the fiscal 2025 compensation of Cencora, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2863084.000000 0.000000 FOR 2863084.000000 FOR S000002922 Cencora, Inc. 03073E105 03/05/2026 Advisory vote to approve the fiscal 2025 compensation of Cencora, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2863084.000000 0.000000 FOR 2863084.000000 FOR 1 S000002922 Cencora, Inc. 03073E105 03/05/2026 Ratification of the appointment of Ernst & Young LLP as Cencora, Inc.'s independent registered public accounting firm for fiscal 2026. AUDIT-RELATED ISSUER 2863084.000000 0.000000 FOR 2863084.000000 FOR S000002922 Novartis AG CH0012005267 03/06/2026 Accounts and Reports CORPORATE GOVERNANCE ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Report on Non-Financial Matters CORPORATE GOVERNANCE ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Ratification of Board and Management Acts CORPORATE GOVERNANCE ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Allocation of Dividends CAPITAL STRUCTURE ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Cancellation of Shares and Reduction in Share Capital CAPITAL STRUCTURE ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Board Compensation COMPENSATION ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Executive Compensation (Total) COMPENSATION ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Compensation Report COMPENSATION ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect Giovanni Caforio as Board Chair DIRECTOR ELECTIONS ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect Nancy C. Andrews DIRECTOR ELECTIONS ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect Ton Buchner DIRECTOR ELECTIONS ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect Patrice Bula DIRECTOR ELECTIONS ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect Elizabeth Doherty DIRECTOR ELECTIONS ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect Bridgette P. Heller DIRECTOR ELECTIONS ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect Frans van Houten DIRECTOR ELECTIONS ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect Elizabeth McNally DIRECTOR ELECTIONS ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect Simon Moroney DIRECTOR ELECTIONS ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect Ana de Pro Gonzalo DIRECTOR ELECTIONS ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect John D. Young DIRECTOR ELECTIONS ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect Charles Swanton DIRECTOR ELECTIONS ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect Patrice Bula as Compensation Committee Member CORPORATE GOVERNANCE ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect Bridgette P. Heller as Compensation Committee Member CORPORATE GOVERNANCE ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect Simon Moroney as Compensation Committee Member CORPORATE GOVERNANCE ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect John D. Young as Compensation Committee Member CORPORATE GOVERNANCE ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Elect Elizabeth McNally as Compensation Committee Member CORPORATE GOVERNANCE ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Appointment of Auditor AUDIT-RELATED ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Appointment of Independent Proxy CORPORATE GOVERNANCE ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Novartis AG CH0012005267 03/06/2026 Transaction of Other Business CORPORATE GOVERNANCE ISSUER 3795144.000000 0.000000 Takenoaction 3795144.000000 NONE S000002922 Agilent Technologies, Inc. 00846U101 03/18/2026 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Judy Gawlik Brown DIRECTOR ELECTIONS ISSUER 3480187.000000 0.000000 FOR 3480187.000000 FOR S000002922 Agilent Technologies, Inc. 00846U101 03/18/2026 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Sue H. Rataj DIRECTOR ELECTIONS ISSUER 3480187.000000 0.000000 FOR 3480187.000000 FOR S000002922 Agilent Technologies, Inc. 00846U101 03/18/2026 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: George A. Scangos, Ph.D. DIRECTOR ELECTIONS ISSUER 3480187.000000 0.000000 FOR 3480187.000000 FOR S000002922 Agilent Technologies, Inc. 00846U101 03/18/2026 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Dow R. Wilson DIRECTOR ELECTIONS ISSUER 3480187.000000 0.000000 FOR 3480187.000000 FOR S000002922 Agilent Technologies, Inc. 00846U101 03/18/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3480187.000000 0.000000 FOR 3480187.000000 FOR S000002922 Agilent Technologies, Inc. 00846U101 03/18/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3480187.000000 0.000000 FOR 3480187.000000 FOR 1 S000002922 Agilent Technologies, Inc. 00846U101 03/18/2026 To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. AUDIT-RELATED ISSUER 3480187.000000 0.000000 FOR 3480187.000000 FOR S000002922 Agilent Technologies, Inc. 00846U101 03/18/2026 To approve an amendment to Agilent's Third Amended and Restated Certificate of Incorporation to declassify the Board of Directors over a three-year period. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 3480187.000000 0.000000 FOR 3480187.000000 FOR S000002922 Genmab A/S DK0010272202 03/19/2026 Accounts and Reports; Ratification of Board and Management Acts CORPORATE GOVERNANCE ISSUER 1345944.000000 0.000000 FOR 1345944.000000 FOR S000002922 Genmab A/S DK0010272202 03/19/2026 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 1345944.000000 0.000000 FOR 1345944.000000 FOR S000002922 Genmab A/S DK0010272202 03/19/2026 Remuneration Report COMPENSATION ISSUER 1345944.000000 0.000000 FOR 1345944.000000 FOR S000002922 Genmab A/S DK0010272202 03/19/2026 Elect Deirdre P. Connelly DIRECTOR ELECTIONS ISSUER 1345944.000000 0.000000 AGAINST 1345944.000000 AGAINST S000002922 Genmab A/S DK0010272202 03/19/2026 Elect Pernille Erenbjerg DIRECTOR ELECTIONS ISSUER 1345944.000000 0.000000 FOR 1345944.000000 FOR S000002922 Genmab A/S DK0010272202 03/19/2026 Elect Rolf Hoffman DIRECTOR ELECTIONS ISSUER 1345944.000000 0.000000 FOR 1345944.000000 FOR S000002922 Genmab A/S DK0010272202 03/19/2026 Elect Elizabeth G. O'Farrell DIRECTOR ELECTIONS ISSUER 1345944.000000 0.000000 FOR 1345944.000000 FOR S000002922 Genmab A/S DK0010272202 03/19/2026 Elect Paolo Paoletti DIRECTOR ELECTIONS ISSUER 1345944.000000 0.000000 FOR 1345944.000000 FOR S000002922 Genmab A/S DK0010272202 03/19/2026 Elect Anders Gersel Pedersen DIRECTOR ELECTIONS ISSUER 1345944.000000 0.000000 FOR 1345944.000000 FOR S000002922 Genmab A/S DK0010272202 03/19/2026 Appointment of Auditor; Appointment of Auditor for Sustainability Reporting AUDIT-RELATED ISSUER 1345944.000000 0.000000 FOR 1345944.000000 FOR S000002922 Genmab A/S DK0010272202 03/19/2026 Directors' Fees COMPENSATION ISSUER 1345944.000000 0.000000 AGAINST 1345944.000000 AGAINST S000002922 Genmab A/S DK0010272202 03/19/2026 Cancellation of Shares CAPITAL STRUCTURE ISSUER 1345944.000000 0.000000 FOR 1345944.000000 FOR S000002922 Genmab A/S DK0010272202 03/19/2026 Authorization of Legal Formalities CORPORATE GOVERNANCE ISSUER 1345944.000000 0.000000 FOR 1345944.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 03/23/2026 Election of Chairman of the Meeting CORPORATE GOVERNANCE ISSUER 1103469.000000 0.000000 FOR 1103469.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 03/23/2026 Presentation of Audited Annual Report with Auditor's Statement for Approval and Discharge of the Board of Directors and Management CORPORATE GOVERNANCE ISSUER 1103469.000000 0.000000 FOR 1103469.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 03/23/2026 Resolution on Application of Profits or Covering of Losses as per the Adopted Annual Report CAPITAL STRUCTURE ISSUER 1103469.000000 0.000000 FOR 1103469.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 03/23/2026 Elect Albert Cha DIRECTOR ELECTIONS ISSUER 1103469.000000 0.000000 FOR 1103469.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 03/23/2026 Elect Lars Holtug DIRECTOR ELECTIONS ISSUER 1103469.000000 0.000000 FOR 1103469.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 03/23/2026 Elect Jan Moller Mikkelsen DIRECTOR ELECTIONS ISSUER 1103469.000000 0.000000 FOR 1103469.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 03/23/2026 Elect Lisa Jane Morrison DIRECTOR ELECTIONS ISSUER 1103469.000000 0.000000 FOR 1103469.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 03/23/2026 Elect William Fairey DIRECTOR ELECTIONS ISSUER 1103469.000000 0.000000 FOR 1103469.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 03/23/2026 Elect Siham Imani DIRECTOR ELECTIONS ISSUER 1103469.000000 0.000000 FOR 1103469.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 03/23/2026 Elect Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 1103469.000000 0.000000 FOR 1103469.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 03/23/2026 Election of State-authorized Public Auditor AUDIT-RELATED ISSUER 1103469.000000 0.000000 FOR 1103469.000000 FOR S000002922 Ascendis Pharma A/S 04351P101 03/23/2026 Proposal from the board of directors: Authorization to the Board of Directors to allow the Company to repurchase own shares or American Depositary Shares. CAPITAL STRUCTURE ISSUER 1103469.000000 0.000000 FOR 1103469.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/26/2026 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 7912642.000000 0.000000 FOR 7912642.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/26/2026 Elect Osamu Okuda DIRECTOR ELECTIONS ISSUER 7912642.000000 0.000000 FOR 7912642.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/26/2026 Elect Iwaaki Taniguchi DIRECTOR ELECTIONS ISSUER 7912642.000000 0.000000 FOR 7912642.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/26/2026 Elect Hitoshi Iikura DIRECTOR ELECTIONS ISSUER 7912642.000000 0.000000 FOR 7912642.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/26/2026 Elect Fumio Tateishi DIRECTOR ELECTIONS ISSUER 7912642.000000 0.000000 FOR 7912642.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/26/2026 Elect Hideo Teramoto DIRECTOR ELECTIONS ISSUER 7912642.000000 0.000000 FOR 7912642.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/26/2026 Elect Kinuko Mitani DIRECTOR ELECTIONS ISSUER 7912642.000000 0.000000 FOR 7912642.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/26/2026 Elect Thomas Schinecker DIRECTOR ELECTIONS ISSUER 7912642.000000 0.000000 FOR 7912642.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/26/2026 Elect Teresa A. Graham DIRECTOR ELECTIONS ISSUER 7912642.000000 0.000000 FOR 7912642.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/26/2026 Elect Boris L. Zaitra DIRECTOR ELECTIONS ISSUER 7912642.000000 0.000000 FOR 7912642.000000 FOR S000002922 CHUGAI PHARMACEUTICAL CO.,LTD. JP3519400000 03/26/2026 Trust Type Equity Plans COMPENSATION ISSUER 7912642.000000 0.000000 FOR 7912642.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Accounts and Reports CORPORATE GOVERNANCE ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Remuneration Report COMPENSATION ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Directors' Fees (2025) COMPENSATION ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Directors' Fees (2026) COMPENSATION ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Elect Lars Rebien Sorensen as Chair of the Board DIRECTOR ELECTIONS ISSUER 6105057.000000 0.000000 ABSTAIN 6105057.000000 AGAINST S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Elect Cornelis (Cees) de Jong as Vice Chair of the Board DIRECTOR ELECTIONS ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Elect Britt Meelby Jensen DIRECTOR ELECTIONS ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Elect Kasim Kutay DIRECTOR ELECTIONS ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Elect Stephan Engels DIRECTOR ELECTIONS ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Elect Helena Saxon DIRECTOR ELECTIONS ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Elect Jan van de Winkel DIRECTOR ELECTIONS ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Elect Ramona Sequeira DIRECTOR ELECTIONS ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Appointment of Auditor; Appointment of Auditor for Sustainability Reporting AUDIT-RELATED ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Authority to Repurchase Shares CAPITAL STRUCTURE ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Authority to Issue Shares w/ or w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Novo Nordisk A/S DK0062498333 03/26/2026 Amendments to Articles (Meeting Location) CORPORATE GOVERNANCE ISSUER 6105057.000000 0.000000 FOR 6105057.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Ichiro Otsuka DIRECTOR ELECTIONS ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Makoto Inoue DIRECTOR ELECTIONS ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Yoshiro Matsuo DIRECTOR ELECTIONS ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Yuko Makino DIRECTOR ELECTIONS ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Shuichi Takagi DIRECTOR ELECTIONS ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Masayuki Kobayashi DIRECTOR ELECTIONS ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Noriko Tojo DIRECTOR ELECTIONS ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Tatsuo Higuchi DIRECTOR ELECTIONS ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Yukio Matsutani DIRECTOR ELECTIONS ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Yoshihisa Aoki DIRECTOR ELECTIONS ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Mayo Mita @ Mayo Nakatsuka DIRECTOR ELECTIONS ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Tatsuaki Kitachi DIRECTOR ELECTIONS ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Jiro Seguchi DIRECTOR ELECTIONS ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Yozo Toba CORPORATE GOVERNANCE ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Hiroshi Sugawara CORPORATE GOVERNANCE ISSUER 7893800.000000 0.000000 AGAINST 7893800.000000 AGAINST S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Kanako Osawa @ Kanako Koike CORPORATE GOVERNANCE ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 Otsuka Holdings Co., Ltd. JP3188220002 03/27/2026 Elect Sachie Tsuji @ Sachie Ueda CORPORATE GOVERNANCE ISSUER 7893800.000000 0.000000 FOR 7893800.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Accounts and Reports CORPORATE GOVERNANCE ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Appointment of Auditor AUDIT-RELATED ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Authority to Set Auditor's Fees AUDIT-RELATED ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Elect Michel Demare DIRECTOR ELECTIONS ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Elect Pascal Soriot DIRECTOR ELECTIONS ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Elect Aradhana Sarin DIRECTOR ELECTIONS ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Elect Philip Broadley DIRECTOR ELECTIONS ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Elect Euan Ashley DIRECTOR ELECTIONS ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Elect Birgit Conix DIRECTOR ELECTIONS ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Elect Rene Haas DIRECTOR ELECTIONS ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Elect Karen Knudsen DIRECTOR ELECTIONS ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Elect Diana Layfield DIRECTOR ELECTIONS ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Elect Anna Manz DIRECTOR ELECTIONS ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Elect Sherilyn S. McCoy DIRECTOR ELECTIONS ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Elect Tony MOK Shu Kam DIRECTOR ELECTIONS ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Elect Marcus Wallenberg DIRECTOR ELECTIONS ISSUER 9897175.000000 0.000000 AGAINST 9897175.000000 AGAINST S000002922 AstraZeneca plc GB0009895292 04/09/2026 Remuneration Report COMPENSATION ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Performance Share Plan COMPENSATION ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Authorisation of Political Donations OTHER SOCIAL ISSUES ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Authority to Issue Shares w/ Preemptive Rights CAPITAL STRUCTURE ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Authority to Issue Shares w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment) CAPITAL STRUCTURE ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Authority to Repurchase Shares CAPITAL STRUCTURE ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 AstraZeneca plc GB0009895292 04/09/2026 Authority to Set General Meeting Notice Period at 14 Days CORPORATE GOVERNANCE ISSUER 9897175.000000 0.000000 FOR 9897175.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 TO CONSIDER AND APPROVE THE WORK REPORT OF THE BOARD OF DIRECTORS (THE 'BOARD') OF THE COMPANY OF 2025 CORPORATE GOVERNANCE ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 TO CONSIDER AND APPROVE THE COMPANY'S ANNUAL REPORT OF 2025 CORPORATE GOVERNANCE ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 TO CONSIDER AND APPROVE THE COMPANY'S PROPOSED PROFIT DISTRIBUTION PLAN FOR 2025 AND THE PROPOSED AUTHORIZATION TO THE BOARD TO FORMULATE THE COMPANY'S INTERIM DIVIDEND PLAN FOR 2026 CAPITAL STRUCTURE ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 TO CONSIDER AND APPROVE THE PROPOSED RE-APPOINTMENT OF AUDITORS AUDIT-RELATED ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 TO CONSIDER AND APPROVE THE REMUNERATION OF THE DIRECTORS (THE 'DIRECTORS') AND SENIOR MANAGEMENT MEMBERS ('SENIOR MANAGEMENT MEMBERS') OF THE COMPANY FOR 2025 COMPENSATION ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 TO CONSIDER AND APPROVE THE PROPOSED PURCHASE OF LIABILITY INSURANCE FOR THE DIRECTORS AND SENIOR MANAGEMENT MEMBERS CORPORATE GOVERNANCE ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 TO CONSIDER AND APPROVE THE RESOLUTION ON THE GENERAL MANDATE TO ISSUE SHARES OF THE COMPANY (THE 'SHARES') CAPITAL STRUCTURE ISSUER 9939973.000000 0.000000 AGAINST 9939973.000000 AGAINST S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 THE PROPOSED AMENDMENTS TO THE RULES OF PROCEDURE OF THE SHAREHOLDERS' MEETINGS CORPORATE GOVERNANCE ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 THE PROPOSED AMENDMENTS TO THE RULES OF PROCEDURE OF THE BOARD CORPORATE GOVERNANCE ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 THE ADOPTION OF THE MANAGEMENT POLICY FOR REMUNERATION OF DIRECTORS AND SENIOR MANAGEMENT MEMBERS CORPORATE GOVERNANCE ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 TO CONSIDER AND APPROVE THE PROPOSED REMUNERATION PLAN FOR THE DIRECTORS AND SENIOR MANAGEMENT MEMBERS COMPENSATION ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 THE ELECTION OF 'MR. SUN PIAOYANG' AS AN EXECUTIVE DIRECTOR DIRECTOR ELECTIONS ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 THE ELECTION OF 'MR. DAI HONGBIN' AS AN EXECUTIVE DIRECTOR DIRECTOR ELECTIONS ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 THE ELECTION OF 'MS. FENG JI' AS AN EXECUTIVE DIRECTOR DIRECTOR ELECTIONS ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 THE ELECTION OF 'MR. ZHANG LIANSHAN' AS AN EXECUTIVE DIRECTOR DIRECTOR ELECTIONS ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 THE ELECTION OF 'MR. JIANG FRANK NINGJUN' AS AN EXECUTIVE DIRECTOR DIRECTOR ELECTIONS ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 THE ELECTION OF 'MS. GUO CONGZHAO' AS A NON-EXECUTIVE DIRECTOR DIRECTOR ELECTIONS ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 THE ELECTION OF 'MR. LOU LIGUANG' AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR DIRECTOR ELECTIONS ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 THE ELECTION OF 'MR. ZENG QINGSHENG' AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR DIRECTOR ELECTIONS ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 THE ELECTION OF 'MR. SUN JINYUN' AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR DIRECTOR ELECTIONS ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Jiangsu Hengrui Pharmaceuticals Co. Ltd. CNE100006XS6 04/16/2026 THE ELECTION OF 'MR. CHOW KYAN MERVYN' AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR DIRECTOR ELECTIONS ISSUER 9939973.000000 0.000000 FOR 9939973.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Accounts and Reports CORPORATE GOVERNANCE ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Report on Non-Financial Matters CORPORATE GOVERNANCE ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Compensation Report COMPENSATION ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Allocation of Profits; Dividend from Reserves CAPITAL STRUCTURE ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Ratification of Board and Management Acts CORPORATE GOVERNANCE ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Elect Thomas Ebeling as Board Chair DIRECTOR ELECTIONS ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Elect L. Daniel Browne DIRECTOR ELECTIONS ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Elect Maria Teresa Hilado DIRECTOR ELECTIONS ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Elect Karen L. Ling DIRECTOR ELECTIONS ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Elect Roberto de Oliveira Marques DIRECTOR ELECTIONS ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Elect Sherilyn S. McCoy DIRECTOR ELECTIONS ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Elect Flemming Ornskov DIRECTOR ELECTIONS ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Elect Harry Kirsch DIRECTOR ELECTIONS ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Shareholder Proposal Regarding Election of Samuel du Retail DIRECTOR ELECTIONS ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Shareholder Proposal Regarding Election of Delphine Viguier-Hovasse DIRECTOR ELECTIONS ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Elect Karen L. Ling as Compensation Committee Member CORPORATE GOVERNANCE ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Elect Thomas Ebeling as Compensation Committee Member CORPORATE GOVERNANCE ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Elect Roberto de Oliveira Marques as Compensation Committee Member CORPORATE GOVERNANCE ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Board Compensation COMPENSATION ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Executive Compensation (Total) COMPENSATION ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Appointment of Independent Proxy CORPORATE GOVERNANCE ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Appointment of Auditor AUDIT-RELATED ISSUER 2320400.000000 0.000000 FOR 2320400.000000 FOR S000002922 Galderma Group AG CH1335392721 04/22/2026 Transaction of Other Business CORPORATE GOVERNANCE ISSUER 2320400.000000 0.000000 AGAINST 2320400.000000 NONE S000002922 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Thomas F. Frist III DIRECTOR ELECTIONS ISSUER 933410.000000 0.000000 FOR 933410.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Samuel N. Hazen DIRECTOR ELECTIONS ISSUER 933410.000000 0.000000 FOR 933410.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: John W. Chidsey, III DIRECTOR ELECTIONS ISSUER 933410.000000 0.000000 FOR 933410.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Nancy-Ann DeParle DIRECTOR ELECTIONS ISSUER 933410.000000 0.000000 FOR 933410.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: William R. Frist DIRECTOR ELECTIONS ISSUER 933410.000000 0.000000 FOR 933410.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Hugh F. Johnston DIRECTOR ELECTIONS ISSUER 933410.000000 0.000000 FOR 933410.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Michael W. Michelson DIRECTOR ELECTIONS ISSUER 933410.000000 0.000000 FOR 933410.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Wayne J. Riley, M.D. DIRECTOR ELECTIONS ISSUER 933410.000000 0.000000 FOR 933410.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Andrea B. Smith DIRECTOR ELECTIONS ISSUER 933410.000000 0.000000 FOR 933410.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/23/2026 To ratify the appointment of Ernst & Young LLP as our Independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 933410.000000 0.000000 FOR 933410.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/23/2026 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 933410.000000 0.000000 FOR 933410.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/23/2026 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 933410.000000 0.000000 FOR 933410.000000 FOR 1 S000002922 HCA Healthcare, Inc. 40412C101 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences. OTHER SOCIAL ISSUES SECURITY HOLDER 933410.000000 0.000000 AGAINST 933410.000000 FOR S000002922 HCA Healthcare, Inc. 40412C101 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding shareholders' right to act by written consent. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 933410.000000 0.000000 AGAINST 933410.000000 FOR S000002922 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Mary C. Beckerle DIRECTOR ELECTIONS ISSUER 5367039.000000 0.000000 FOR 5367039.000000 FOR S000002922 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 5367039.000000 0.000000 FOR 5367039.000000 FOR S000002922 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Joaquin Duato DIRECTOR ELECTIONS ISSUER 5367039.000000 0.000000 FOR 5367039.000000 FOR S000002922 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Marillyn A. Hewson DIRECTOR ELECTIONS ISSUER 5367039.000000 0.000000 FOR 5367039.000000 FOR S000002922 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Paula A. Johnson DIRECTOR ELECTIONS ISSUER 5367039.000000 0.000000 FOR 5367039.000000 FOR S000002922 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Hubert Joly DIRECTOR ELECTIONS ISSUER 5367039.000000 0.000000 FOR 5367039.000000 FOR S000002922 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Mark B. McClellan DIRECTOR ELECTIONS ISSUER 5367039.000000 0.000000 FOR 5367039.000000 FOR S000002922 Johnson & Johnson 478160104 04/23/2026 Election of Directors: John G. Morikis DIRECTOR ELECTIONS ISSUER 5367039.000000 0.000000 FOR 5367039.000000 FOR S000002922 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Daniel E. Pinto DIRECTOR ELECTIONS ISSUER 5367039.000000 0.000000 FOR 5367039.000000 FOR S000002922 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Mark A. Weinberger DIRECTOR ELECTIONS ISSUER 5367039.000000 0.000000 FOR 5367039.000000 FOR S000002922 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Nadja Y. West DIRECTOR ELECTIONS ISSUER 5367039.000000 0.000000 FOR 5367039.000000 FOR S000002922 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Eugene A. Woods DIRECTOR ELECTIONS ISSUER 5367039.000000 0.000000 FOR 5367039.000000 FOR S000002922 Johnson & Johnson 478160104 04/23/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 5367039.000000 0.000000 FOR 5367039.000000 FOR S000002922 Johnson & Johnson 478160104 04/23/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 5367039.000000 0.000000 FOR 5367039.000000 FOR 1 S000002922 Johnson & Johnson 478160104 04/23/2026 Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 5367039.000000 0.000000 FOR 5367039.000000 FOR S000002922 Johnson & Johnson 478160104 04/23/2026 Independent Board Chair CORPORATE GOVERNANCE SECURITY HOLDER 5367039.000000 0.000000 AGAINST 5367039.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Election of Directors: N. Ahuja DIRECTOR ELECTIONS ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Election of Directors: C. Babineaux-Fontenot DIRECTOR ELECTIONS ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Election of Directors: S. E. Blount DIRECTOR ELECTIONS ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Election of Directors: R. B. Ford DIRECTOR ELECTIONS ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Election of Directors: P. Gonzalez DIRECTOR ELECTIONS ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Election of Directors: M. A. Kumbier DIRECTOR ELECTIONS ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Election of Directors: D. W. McDew DIRECTOR ELECTIONS ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Election of Directors: N. McKinstry DIRECTOR ELECTIONS ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Election of Directors: M. G. O Grady DIRECTOR ELECTIONS ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Election of Directors: M. F. Roman DIRECTOR ELECTIONS ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Election of Directors: D. J. Starks DIRECTOR ELECTIONS ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Election of Directors: J. G. Stratton DIRECTOR ELECTIONS ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Ratification of Ernst & Young LLP As Auditors AUDIT-RELATED ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR 1 S000002922 Abbott Laboratories 002824100 04/24/2026 Approval of the Abbott Laboratories 2026 Incentive Stock Program COMPENSATION ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Abbott Laboratories 002824100 04/24/2026 Approval of the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees COMPENSATION ISSUER 9990500.000000 0.000000 FOR 9990500.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 04/29/2026 Issuance of RMB Shares under Specific Mandate CAPITAL STRUCTURE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 04/29/2026 Board Authorization to Handle Matters relating to the RMB Share Issue CORPORATE GOVERNANCE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 04/29/2026 Approval of the Plan for Undertaking Accumulated Unrecovered Loss Prior to the RMB Share Issue CAPITAL STRUCTURE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 04/29/2026 Approval of the Plan for Stabilization of the Price of RMB Shares CAPITAL STRUCTURE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 04/29/2026 Approval of the Dividend Return Plan for the Three Years after the RMB Share Issue CAPITAL STRUCTURE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 04/29/2026 Use of Proceeds from the RMB Share Issue CAPITAL STRUCTURE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 04/29/2026 Remedial Measures for the Dilution of Immediate Returns after the RMB Share Issue CAPITAL STRUCTURE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 04/29/2026 Approval of the Undertaking and Corresponding Binding Measures in connection with the RMB Share Issue CAPITAL STRUCTURE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 04/29/2026 Adoption of Rules of Procedures for Shareholders' General Meetings CORPORATE GOVERNANCE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 04/29/2026 Adoption of Rules of Procedures for Board Meetings CORPORATE GOVERNANCE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 04/29/2026 Board Authorization CORPORATE GOVERNANCE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 04/29/2026 Amendments to Articles CORPORATE GOVERNANCE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: David C. Habiger DIRECTOR ELECTIONS ISSUER 10021800.000000 0.000000 AGAINST 10021800.000000 AGAINST S000002922 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Edward J. Ludwig DIRECTOR ELECTIONS ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Jessica L. Mega DIRECTOR ELECTIONS ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Susan E Morano DIRECTOR ELECTIONS ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Cheryl Pegus DIRECTOR ELECTIONS ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Catherine R. Smith DIRECTOR ELECTIONS ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Christophe P. Weber DIRECTOR ELECTIONS ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: David S. Wichmann DIRECTOR ELECTIONS ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR 1 S000002922 Boston Scientific Corporation 101137107 04/30/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance. COMPENSATION ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 To amend our Certificate of Incorporation to remove supermajority voting provisions. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock to call a special meeting of stockholders. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 10021800.000000 0.000000 FOR 10021800.000000 FOR S000002922 Boston Scientific Corporation 101137107 04/30/2026 Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 10021800.000000 0.000000 FOR 10021800.000000 AGAINST S000002922 Inspire Medical Systems, Inc. 457730109 04/30/2026 Elect Gary L. Ellis DIRECTOR ELECTIONS ISSUER 1473622.000000 0.000000 FOR 1473622.000000 FOR S000002922 Inspire Medical Systems, Inc. 457730109 04/30/2026 Elect Georgia Melenikiotou DIRECTOR ELECTIONS ISSUER 1473622.000000 0.000000 FOR 1473622.000000 FOR S000002922 Inspire Medical Systems, Inc. 457730109 04/30/2026 Elect Dana G. Mead, Jr. DIRECTOR ELECTIONS ISSUER 1473622.000000 0.000000 FOR 1473622.000000 FOR S000002922 Inspire Medical Systems, Inc. 457730109 04/30/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1473622.000000 0.000000 FOR 1473622.000000 FOR S000002922 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1473622.000000 0.000000 FOR 1473622.000000 FOR S000002922 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1473622.000000 0.000000 FOR 1473622.000000 FOR 1 S000002922 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval, on an advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1473622.000000 0.000000 ONE YEAR 1473622.000000 FOR S000002922 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval, on an advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1473622.000000 0.000000 ONE YEAR 1473622.000000 FOR 1 S000002922 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to phase out the classified Board structure and provide for the annual election of all directors beginning with the Company's 2029 annual meeting of stockholders. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 1473622.000000 0.000000 FOR 1473622.000000 FOR S000002922 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan. COMPENSATION ISSUER 1473622.000000 0.000000 FOR 1473622.000000 FOR S000002922 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal No. 5 and/or Proposal No. 6. CORPORATE GOVERNANCE ISSUER 1473622.000000 0.000000 FOR 1473622.000000 FOR S000002922 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Craig H. Barratt, Ph.D. DIRECTOR ELECTIONS ISSUER 2025229.000000 0.000000 FOR 2025229.000000 FOR S000002922 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Joseph C. Beery DIRECTOR ELECTIONS ISSUER 2025229.000000 0.000000 FOR 2025229.000000 FOR S000002922 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Lewis Chew DIRECTOR ELECTIONS ISSUER 2025229.000000 0.000000 FOR 2025229.000000 FOR S000002922 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 2025229.000000 0.000000 FOR 2025229.000000 FOR S000002922 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 2025229.000000 0.000000 FOR 2025229.000000 FOR S000002922 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Amy L. Ladd, M.D. DIRECTOR ELECTIONS ISSUER 2025229.000000 0.000000 FOR 2025229.000000 FOR S000002922 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Keith R. Leonard, Jr. DIRECTOR ELECTIONS ISSUER 2025229.000000 0.000000 FOR 2025229.000000 FOR S000002922 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Jami Dover Nachtsheim DIRECTOR ELECTIONS ISSUER 2025229.000000 0.000000 FOR 2025229.000000 FOR S000002922 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Monica P. Reed, M.D. DIRECTOR ELECTIONS ISSUER 2025229.000000 0.000000 FOR 2025229.000000 FOR S000002922 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: David J. Rosa DIRECTOR ELECTIONS ISSUER 2025229.000000 0.000000 FOR 2025229.000000 FOR S000002922 Intuitive Surgical, Inc. 46120E602 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2025229.000000 0.000000 FOR 2025229.000000 FOR S000002922 Intuitive Surgical, Inc. 46120E602 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2025229.000000 0.000000 FOR 2025229.000000 FOR 1 S000002922 Intuitive Surgical, Inc. 46120E602 04/30/2026 The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2025229.000000 0.000000 FOR 2025229.000000 FOR S000002922 Intuitive Surgical, Inc. 46120E602 04/30/2026 To approve the amendment and restatement of the Company's Amended and Restated 2010 Incentive Award Plan. COMPENSATION ISSUER 2025229.000000 0.000000 FOR 2025229.000000 FOR S000002922 UCB SA BE0003739530 04/30/2026 Accounts and Reports; Allocation of Dividends CAPITAL STRUCTURE ISSUER 2427158.000000 0.000000 FOR 2427158.000000 FOR S000002922 UCB SA BE0003739530 04/30/2026 Remuneration Report COMPENSATION ISSUER 2427158.000000 0.000000 FOR 2427158.000000 FOR S000002922 UCB SA BE0003739530 04/30/2026 Ratification of Board Acts CORPORATE GOVERNANCE ISSUER 2427158.000000 0.000000 FOR 2427158.000000 FOR S000002922 UCB SA BE0003739530 04/30/2026 Ratification of Auditor's Acts CORPORATE GOVERNANCE ISSUER 2427158.000000 0.000000 FOR 2427158.000000 FOR S000002922 UCB SA BE0003739530 04/30/2026 Elect Jean-Christophe Tellier to the Board of Directors DIRECTOR ELECTIONS ISSUER 2427158.000000 0.000000 FOR 2427158.000000 FOR S000002922 UCB SA BE0003739530 04/30/2026 Elect Cedric Van Rijckevorsel to the Board of Directors DIRECTOR ELECTIONS ISSUER 2427158.000000 0.000000 FOR 2427158.000000 FOR S000002922 UCB SA BE0003739530 04/30/2026 Change in Control Clause SHAREHOLDER RIGHTS AND DEFENSES ISSUER 2427158.000000 0.000000 FOR 2427158.000000 FOR S000002922 UCB SA BE0003739530 04/30/2026 Increase in Authorised Capital CAPITAL STRUCTURE ISSUER 2427158.000000 0.000000 FOR 2427158.000000 FOR S000002922 UCB SA BE0003739530 04/30/2026 Authority to Repurchase Shares CAPITAL STRUCTURE ISSUER 2427158.000000 0.000000 FOR 2427158.000000 FOR S000002922 Eli Lilly and Company 532457108 05/04/2026 Election of the following directors, each to serve a three-year term: Carolyn Bertozzi DIRECTOR ELECTIONS ISSUER 3619771.000000 0.000000 FOR 3619771.000000 FOR S000002922 Eli Lilly and Company 532457108 05/04/2026 Election of the following directors, each to serve a three-year term: William Kaelin, Jr. DIRECTOR ELECTIONS ISSUER 3619771.000000 0.000000 FOR 3619771.000000 FOR S000002922 Eli Lilly and Company 532457108 05/04/2026 Election of the following directors, each to serve a three-year term: Jon Moeller DIRECTOR ELECTIONS ISSUER 3619771.000000 0.000000 FOR 3619771.000000 FOR S000002922 Eli Lilly and Company 532457108 05/04/2026 Election of the following directors, each to serve a three-year term: David Ricks DIRECTOR ELECTIONS ISSUER 3619771.000000 0.000000 FOR 3619771.000000 FOR S000002922 Eli Lilly and Company 532457108 05/04/2026 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3619771.000000 0.000000 FOR 3619771.000000 FOR S000002922 Eli Lilly and Company 532457108 05/04/2026 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3619771.000000 0.000000 FOR 3619771.000000 FOR 1 S000002922 Eli Lilly and Company 532457108 05/04/2026 Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2026. AUDIT-RELATED ISSUER 3619771.000000 0.000000 FOR 3619771.000000 FOR S000002922 Eli Lilly and Company 532457108 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate the classified board structure. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 3619771.000000 0.000000 FOR 3619771.000000 FOR S000002922 Eli Lilly and Company 532457108 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate supermajority voting provisions. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 3619771.000000 0.000000 FOR 3619771.000000 FOR S000002922 Eli Lilly and Company 532457108 05/04/2026 Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. CORPORATE GOVERNANCE SECURITY HOLDER 3619771.000000 0.000000 FOR 3619771.000000 AGAINST S000002922 Eli Lilly and Company 532457108 05/04/2026 Shareholder proposal to prepare an annual lobbying report. OTHER SOCIAL ISSUES SECURITY HOLDER 3619771.000000 0.000000 AGAINST 3619771.000000 FOR S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 4606141.000000 0.000000 FOR 4606141.000000 FOR S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Deepak L. Bhatt, M.D., M.P.H., M.B.A. DIRECTOR ELECTIONS ISSUER 4606141.000000 0.000000 FOR 4606141.000000 FOR S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Christopher S. Boerner, Ph.D. DIRECTOR ELECTIONS ISSUER 4606141.000000 0.000000 FOR 4606141.000000 FOR S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Julia A. Haller, M.D. DIRECTOR ELECTIONS ISSUER 4606141.000000 0.000000 FOR 4606141.000000 FOR S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Manuel Hidalgo Medina, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 4606141.000000 0.000000 FOR 4606141.000000 FOR S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Michael R. McMullen DIRECTOR ELECTIONS ISSUER 4606141.000000 0.000000 FOR 4606141.000000 FOR S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Paula A. Price DIRECTOR ELECTIONS ISSUER 4606141.000000 0.000000 FOR 4606141.000000 FOR S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Derica W. Rice DIRECTOR ELECTIONS ISSUER 4606141.000000 0.000000 AGAINST 4606141.000000 AGAINST S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 4606141.000000 0.000000 FOR 4606141.000000 FOR S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Karen H. Vousden, Ph.D. DIRECTOR ELECTIONS ISSUER 4606141.000000 0.000000 FOR 4606141.000000 FOR S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 4606141.000000 0.000000 FOR 4606141.000000 FOR S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 4606141.000000 0.000000 FOR 4606141.000000 FOR S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 4606141.000000 0.000000 FOR 4606141.000000 FOR 1 S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Vote to Approve the Company's 2026 Stock Award and Incentive Plan COMPENSATION ISSUER 4606141.000000 0.000000 FOR 4606141.000000 FOR S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Ratification of the Appointment of an Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 4606141.000000 0.000000 FOR 4606141.000000 FOR S000002922 Bristol-Myers Squibb Company 110122108 05/05/2026 Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director CORPORATE GOVERNANCE SECURITY HOLDER 4606141.000000 0.000000 FOR 4606141.000000 AGAINST S000002922 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair DIRECTOR ELECTIONS ISSUER 4836473.000000 0.000000 FOR 4836473.000000 FOR S000002922 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan DIRECTOR ELECTIONS ISSUER 4836473.000000 0.000000 FOR 4836473.000000 FOR S000002922 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler DIRECTOR ELECTIONS ISSUER 4836473.000000 0.000000 FOR 4836473.000000 FOR S000002922 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. Lamanna DIRECTOR ELECTIONS ISSUER 4836473.000000 0.000000 FOR 4836473.000000 FOR S000002922 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri L. List DIRECTOR ELECTIONS ISSUER 4836473.000000 0.000000 FOR 4836473.000000 FOR S000002922 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales DIRECTOR ELECTIONS ISSUER 4836473.000000 0.000000 FOR 4836473.000000 FOR S000002922 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales DIRECTOR ELECTIONS ISSUER 4836473.000000 0.000000 FOR 4836473.000000 FOR S000002922 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders DIRECTOR ELECTIONS ISSUER 4836473.000000 0.000000 FOR 4836473.000000 FOR S000002922 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon DIRECTOR ELECTIONS ISSUER 4836473.000000 0.000000 FOR 4836473.000000 FOR S000002922 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D DIRECTOR ELECTIONS ISSUER 4836473.000000 0.000000 FOR 4836473.000000 FOR S000002922 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD DIRECTOR ELECTIONS ISSUER 4836473.000000 0.000000 FOR 4836473.000000 FOR S000002922 Danaher Corporation 235851102 05/05/2026 To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 4836473.000000 0.000000 FOR 4836473.000000 FOR S000002922 Danaher Corporation 235851102 05/05/2026 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4836473.000000 0.000000 FOR 4836473.000000 FOR S000002922 Danaher Corporation 235851102 05/05/2026 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4836473.000000 0.000000 FOR 4836473.000000 FOR 1 S000002922 Danaher Corporation 235851102 05/05/2026 To approve the Company's Amended and Restated Omnibus Incentive Plan. COMPENSATION ISSUER 4836473.000000 0.000000 FOR 4836473.000000 FOR S000002922 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Election of Directors: Michael J. Fucci DIRECTOR ELECTIONS ISSUER 6702311.000000 727100.000000 FOR 6702311.000000 FOR S000002922 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Election of Directors: Patrice A. Harris DIRECTOR ELECTIONS ISSUER 6702311.000000 727100.000000 FOR 6702311.000000 FOR S000002922 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Election of Directors: Daniel J. Cancelmi DIRECTOR ELECTIONS ISSUER 6702311.000000 727100.000000 FOR 6702311.000000 FOR S000002922 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. COMPENSATION ISSUER 6702311.000000 727100.000000 FOR 6702311.000000 FOR S000002922 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 6702311.000000 727100.000000 FOR 6702311.000000 FOR S000002922 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 6702311.000000 727100.000000 FOR 6702311.000000 FOR 1 S000002922 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 6702311.000000 727100.000000 FOR 6702311.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Remuneration Report COMPENSATION ISSUER 470860.000000 0.000000 FOR 470860.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Accounts and Reports CORPORATE GOVERNANCE ISSUER 470860.000000 0.000000 FOR 470860.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Allocation of Profits CAPITAL STRUCTURE ISSUER 470860.000000 0.000000 FOR 470860.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Ratification of Executives' Acts CORPORATE GOVERNANCE ISSUER 470860.000000 0.000000 FOR 470860.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Ratification of Board Acts CORPORATE GOVERNANCE ISSUER 470860.000000 0.000000 FOR 470860.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Elect Karen Massey to the Board of Directors DIRECTOR ELECTIONS ISSUER 470860.000000 0.000000 FOR 470860.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Elect Tim Van Hauwermeiren to the Board of Directors DIRECTOR ELECTIONS ISSUER 470860.000000 0.000000 FOR 470860.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Elect Ana Cespedes to the Board of Directors DIRECTOR ELECTIONS ISSUER 470860.000000 0.000000 FOR 470860.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Elect Camilla Sylvest to the Board of Directors DIRECTOR ELECTIONS ISSUER 470860.000000 0.000000 FOR 470860.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Elect Pamela Klein to the Board of Directors DIRECTOR ELECTIONS ISSUER 470860.000000 0.000000 FOR 470860.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Authority to Issue Shares w/ or w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 470860.000000 0.000000 FOR 470860.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Appointment of Auditor AUDIT-RELATED ISSUER 470860.000000 0.000000 FOR 470860.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Remuneration Report COMPENSATION ISSUER 675226.000000 0.000000 FOR 675226.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Accounts and Reports CORPORATE GOVERNANCE ISSUER 675226.000000 0.000000 FOR 675226.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Allocation of Profits CAPITAL STRUCTURE ISSUER 675226.000000 0.000000 FOR 675226.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Ratification of Executives' Acts CORPORATE GOVERNANCE ISSUER 675226.000000 0.000000 FOR 675226.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Ratification of Board Acts CORPORATE GOVERNANCE ISSUER 675226.000000 0.000000 FOR 675226.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Elect Karen Massey to the Board of Directors DIRECTOR ELECTIONS ISSUER 675226.000000 0.000000 FOR 675226.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Elect Tim Van Hauwermeiren to the Board of Directors DIRECTOR ELECTIONS ISSUER 675226.000000 0.000000 FOR 675226.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Elect Ana Cespedes to the Board of Directors DIRECTOR ELECTIONS ISSUER 675226.000000 0.000000 FOR 675226.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Elect Camilla Sylvest to the Board of Directors DIRECTOR ELECTIONS ISSUER 675226.000000 0.000000 FOR 675226.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Elect Pamela Klein to the Board of Directors DIRECTOR ELECTIONS ISSUER 675226.000000 0.000000 FOR 675226.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Authority to Issue Shares w/ or w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 675226.000000 0.000000 FOR 675226.000000 FOR S000002922 argenx SE NL0010832176 05/06/2026 Appointment of Auditor AUDIT-RELATED ISSUER 675226.000000 0.000000 FOR 675226.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Accounts and Reports CORPORATE GOVERNANCE ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Remuneration Report COMPENSATION ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Amendment to Remuneration Policy (NED Fees) COMPENSATION ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Elect Luke V. Miels DIRECTOR ELECTIONS ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Elect Sir Jonathan R. Symonds DIRECTOR ELECTIONS ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Elect Julie Brown DIRECTOR ELECTIONS ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Elect Elizabeth McKee Anderson DIRECTOR ELECTIONS ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Elect Charles A. Bancroft DIRECTOR ELECTIONS ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Elect Hal V. Barron DIRECTOR ELECTIONS ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Elect Anne Beal DIRECTOR ELECTIONS ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Elect Wendy Becker DIRECTOR ELECTIONS ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Elect Harry Dietz DIRECTOR ELECTIONS ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Elect Jeannie Lee DIRECTOR ELECTIONS ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Elect Gavin Screaton DIRECTOR ELECTIONS ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Elect Vishal Sikka DIRECTOR ELECTIONS ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Appointment of Auditor AUDIT-RELATED ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Authority to Set Auditor's Fees AUDIT-RELATED ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Authorisation of Political Donations OTHER SOCIAL ISSUES ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Authority to Issue Shares w/ Preemptive Rights CAPITAL STRUCTURE ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Authority to Issue Shares w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment) CAPITAL STRUCTURE ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Authority to Repurchase Shares CAPITAL STRUCTURE ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Approve Exemption from Statement of the Senior Statutory Auditor's name in published Auditors' Reports CORPORATE GOVERNANCE ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Authority to Set General Meeting Notice Period at 14 Days CORPORATE GOVERNANCE ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 GSK plc GB00BN7SWP63 05/06/2026 Amendments to Articles CORPORATE GOVERNANCE ISSUER 44002585.000000 0.000000 FOR 44002585.000000 FOR S000002922 Moderna, Inc. 60770K107 05/06/2026 To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal. Sandra Horning, M.D. DIRECTOR ELECTIONS ISSUER 1995366.000000 0.000000 FOR 1995366.000000 FOR S000002922 Moderna, Inc. 60770K107 05/06/2026 To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal. Abbas Hussain DIRECTOR ELECTIONS ISSUER 1995366.000000 0.000000 FOR 1995366.000000 FOR S000002922 Moderna, Inc. 60770K107 05/06/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1995366.000000 0.000000 AGAINST 1995366.000000 AGAINST S000002922 Moderna, Inc. 60770K107 05/06/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1995366.000000 0.000000 AGAINST 1995366.000000 AGAINST 1 S000002922 Moderna, Inc. 60770K107 05/06/2026 To approve, on a non-binding, advisory basis, the frequency of future non-binding advisory votes to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1995366.000000 0.000000 ONE YEAR 1995366.000000 FOR S000002922 Moderna, Inc. 60770K107 05/06/2026 To approve, on a non-binding, advisory basis, the frequency of future non-binding advisory votes to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1995366.000000 0.000000 ONE YEAR 1995366.000000 FOR 1 S000002922 Moderna, Inc. 60770K107 05/06/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1995366.000000 0.000000 FOR 1995366.000000 FOR S000002922 Stryker Corporation 863667101 05/06/2026 Election of Directors: Mary K. Brainerd DIRECTOR ELECTIONS ISSUER 748338.000000 0.000000 FOR 748338.000000 FOR S000002922 Stryker Corporation 863667101 05/06/2026 Election of Directors: Giovanni Caforio, M.D. DIRECTOR ELECTIONS ISSUER 748338.000000 0.000000 FOR 748338.000000 FOR S000002922 Stryker Corporation 863667101 05/06/2026 Election of Directors: Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 748338.000000 0.000000 FOR 748338.000000 FOR S000002922 Stryker Corporation 863667101 05/06/2026 Election of Directors: Emmanuel P. Maceda DIRECTOR ELECTIONS ISSUER 748338.000000 0.000000 FOR 748338.000000 FOR S000002922 Stryker Corporation 863667101 05/06/2026 Election of Directors: Sherilyn S. McCoy DIRECTOR ELECTIONS ISSUER 748338.000000 0.000000 FOR 748338.000000 FOR S000002922 Stryker Corporation 863667101 05/06/2026 Election of Directors: Rachel M. Ruggeri DIRECTOR ELECTIONS ISSUER 748338.000000 0.000000 FOR 748338.000000 FOR S000002922 Stryker Corporation 863667101 05/06/2026 Election of Directors: Andrew K. Silvernail DIRECTOR ELECTIONS ISSUER 748338.000000 0.000000 FOR 748338.000000 FOR S000002922 Stryker Corporation 863667101 05/06/2026 Election of Directors: Lisa M. Skeete Tatum DIRECTOR ELECTIONS ISSUER 748338.000000 0.000000 FOR 748338.000000 FOR S000002922 Stryker Corporation 863667101 05/06/2026 Election of Directors: Ronda E. Stryker DIRECTOR ELECTIONS ISSUER 748338.000000 0.000000 FOR 748338.000000 FOR S000002922 Stryker Corporation 863667101 05/06/2026 Election of Directors: Rajeev Suri DIRECTOR ELECTIONS ISSUER 748338.000000 0.000000 FOR 748338.000000 FOR S000002922 Stryker Corporation 863667101 05/06/2026 Ratification of appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 748338.000000 0.000000 FOR 748338.000000 FOR S000002922 Stryker Corporation 863667101 05/06/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 748338.000000 0.000000 FOR 748338.000000 FOR S000002922 Stryker Corporation 863667101 05/06/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 748338.000000 0.000000 FOR 748338.000000 FOR 1 S000002922 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Simon Dingemans DIRECTOR ELECTIONS ISSUER 20480758.000000 0.000000 FOR 20480758.000000 FOR S000002922 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Emmanuel Ligner DIRECTOR ELECTIONS ISSUER 20480758.000000 0.000000 FOR 20480758.000000 FOR S000002922 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Gregory Lucier DIRECTOR ELECTIONS ISSUER 20480758.000000 0.000000 FOR 20480758.000000 FOR S000002922 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Dame Louise Makin DIRECTOR ELECTIONS ISSUER 20480758.000000 0.000000 FOR 20480758.000000 FOR S000002922 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Joseph Massaro DIRECTOR ELECTIONS ISSUER 20480758.000000 0.000000 FOR 20480758.000000 FOR S000002922 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Sanjeev Mehra DIRECTOR ELECTIONS ISSUER 20480758.000000 0.000000 FOR 20480758.000000 FOR S000002922 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Mala Murthy DIRECTOR ELECTIONS ISSUER 20480758.000000 0.000000 FOR 20480758.000000 FOR S000002922 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Michael Severino DIRECTOR ELECTIONS ISSUER 20480758.000000 0.000000 FOR 20480758.000000 FOR S000002922 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Gregory Summe DIRECTOR ELECTIONS ISSUER 20480758.000000 0.000000 AGAINST 20480758.000000 AGAINST S000002922 Avantor, Inc. 05352A100 05/07/2026 Advisory Approval of Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 20480758.000000 0.000000 FOR 20480758.000000 FOR S000002922 Avantor, Inc. 05352A100 05/07/2026 Advisory Approval of Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 20480758.000000 0.000000 FOR 20480758.000000 FOR 1 S000002922 Avantor, Inc. 05352A100 05/07/2026 Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 20480758.000000 0.000000 ONE YEAR 20480758.000000 FOR S000002922 Avantor, Inc. 05352A100 05/07/2026 Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 20480758.000000 0.000000 ONE YEAR 20480758.000000 FOR 1 S000002922 Avantor, Inc. 05352A100 05/07/2026 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for 2026 AUDIT-RELATED ISSUER 20480758.000000 0.000000 FOR 20480758.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Leslie C. Davis DIRECTOR ELECTIONS ISSUER 15494610.000000 0.000000 FOR 15494610.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: David T. Feinberg, MD DIRECTOR ELECTIONS ISSUER 15494610.000000 0.000000 FOR 15494610.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Kieran T. Gallahue DIRECTOR ELECTIONS ISSUER 15494610.000000 0.000000 FOR 15494610.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Leslie S. Heisz DIRECTOR ELECTIONS ISSUER 15494610.000000 0.000000 FOR 15494610.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 15494610.000000 0.000000 FOR 15494610.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Steven R. Loranger DIRECTOR ELECTIONS ISSUER 15494610.000000 0.000000 FOR 15494610.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 15494610.000000 0.000000 FOR 15494610.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Nicholas J. Valeriani DIRECTOR ELECTIONS ISSUER 15494610.000000 0.000000 FOR 15494610.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Bernard Zovighian DIRECTOR ELECTIONS ISSUER 15494610.000000 0.000000 FOR 15494610.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 15494610.000000 0.000000 FOR 15494610.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 15494610.000000 0.000000 FOR 15494610.000000 FOR 1 S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2026 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 15494610.000000 0.000000 FOR 15494610.000000 FOR S000002922 Edwards Lifesciences Corporation 28176E108 05/07/2026 Approval of the Amended and Restated Long-Term Stock Incentive Compensation Program COMPENSATION ISSUER 15494610.000000 0.000000 FOR 15494610.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Greg D. Carmichael DIRECTOR ELECTIONS ISSUER 1600016.000000 0.000000 FOR 1600016.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Edward M. Christie III DIRECTOR ELECTIONS ISSUER 1600016.000000 0.000000 FOR 1600016.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Cain A. Hayes DIRECTOR ELECTIONS ISSUER 1600016.000000 0.000000 FOR 1600016.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Joan E. Herman DIRECTOR ELECTIONS ISSUER 1600016.000000 0.000000 FOR 1600016.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Leslye G. Katz DIRECTOR ELECTIONS ISSUER 1600016.000000 0.000000 FOR 1600016.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Kevin J. O'Connor DIRECTOR ELECTIONS ISSUER 1600016.000000 0.000000 FOR 1600016.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Christopher R. Reidy DIRECTOR ELECTIONS ISSUER 1600016.000000 0.000000 FOR 1600016.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 1600016.000000 0.000000 FOR 1600016.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Mark J. Tarr DIRECTOR ELECTIONS ISSUER 1600016.000000 0.000000 FOR 1600016.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Terrance Williams DIRECTOR ELECTIONS ISSUER 1600016.000000 0.000000 FOR 1600016.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/07/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1600016.000000 0.000000 FOR 1600016.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/07/2026 An advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1600016.000000 0.000000 FOR 1600016.000000 FOR S000002922 Encompass Health Corporation 29261A100 05/07/2026 An advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1600016.000000 0.000000 FOR 1600016.000000 FOR 1 S000002922 AbbVie Inc. 00287Y109 05/08/2026 Election of Class II directors: Jennifer L. Davis DIRECTOR ELECTIONS ISSUER 3340328.000000 0.000000 FOR 3340328.000000 FOR S000002922 AbbVie Inc. 00287Y109 05/08/2026 Election of Class II directors: Melody B. Meyer DIRECTOR ELECTIONS ISSUER 3340328.000000 0.000000 FOR 3340328.000000 FOR S000002922 AbbVie Inc. 00287Y109 05/08/2026 Election of Class II directors: Robert A. Michael DIRECTOR ELECTIONS ISSUER 3340328.000000 0.000000 FOR 3340328.000000 FOR S000002922 AbbVie Inc. 00287Y109 05/08/2026 Election of Class II directors: Frederick H. Waddell DIRECTOR ELECTIONS ISSUER 3340328.000000 0.000000 FOR 3340328.000000 FOR S000002922 AbbVie Inc. 00287Y109 05/08/2026 Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 3340328.000000 0.000000 FOR 3340328.000000 FOR S000002922 AbbVie Inc. 00287Y109 05/08/2026 Say on pay - an advisory vote on the approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 3340328.000000 0.000000 FOR 3340328.000000 FOR S000002922 AbbVie Inc. 00287Y109 05/08/2026 Say on pay - an advisory vote on the approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 3340328.000000 0.000000 FOR 3340328.000000 FOR 1 S000002922 AbbVie Inc. 00287Y109 05/08/2026 Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting SHAREHOLDER RIGHTS AND DEFENSES ISSUER 3340328.000000 0.000000 FOR 3340328.000000 FOR S000002922 AbbVie Inc. 00287Y109 05/08/2026 Stockholder proposal - to adopt a policy to require an independent chair CORPORATE GOVERNANCE SECURITY HOLDER 3340328.000000 0.000000 FOR 3340328.000000 AGAINST S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 05/11/2026 Directors' Report CORPORATE GOVERNANCE ISSUER 18491938.000000 0.000000 FOR 18491938.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 05/11/2026 Accounts and Reports CORPORATE GOVERNANCE ISSUER 18491938.000000 0.000000 FOR 18491938.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 05/11/2026 Annual Report CORPORATE GOVERNANCE ISSUER 18491938.000000 0.000000 FOR 18491938.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 05/11/2026 2025 and 2026 Directors' Remuneration Plan COMPENSATION ISSUER 18491938.000000 0.000000 FOR 18491938.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 05/11/2026 Appointment of Auditor and Authority to Set Fees AUDIT-RELATED ISSUER 18491938.000000 0.000000 FOR 18491938.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 05/11/2026 Amendments to the Working Rules for the Independent Non-Executive Directors CORPORATE GOVERNANCE ISSUER 18491938.000000 0.000000 FOR 18491938.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 05/11/2026 Amendments to the Related Party Transaction Managements System CORPORATE GOVERNANCE ISSUER 18491938.000000 0.000000 FOR 18491938.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 05/11/2026 Authority to Repurchase H Shares CAPITAL STRUCTURE ISSUER 18491938.000000 0.000000 FOR 18491938.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 05/11/2026 Authority to Issue Shares w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 18491938.000000 0.000000 AGAINST 18491938.000000 AGAINST S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 05/11/2026 Amendments to the Rules of Procedure for the Shareholders' Meetings CORPORATE GOVERNANCE ISSUER 18491938.000000 0.000000 FOR 18491938.000000 FOR S000002922 GenFleet Therapeutics (Shanghai) Inc. CNE1000074L2 05/11/2026 Amendments to the Rules of Procedure for the Board of Directors CORPORATE GOVERNANCE ISSUER 18491938.000000 0.000000 FOR 18491938.000000 FOR S000002922 Elevance Health, Inc. 036752103 05/13/2026 Election of Directors: Gail K. Boudreaux DIRECTOR ELECTIONS ISSUER 1879405.000000 0.000000 FOR 1879405.000000 FOR S000002922 Elevance Health, Inc. 036752103 05/13/2026 Election of Directors: Robert L. Dixon, Jr. DIRECTOR ELECTIONS ISSUER 1879405.000000 0.000000 FOR 1879405.000000 FOR S000002922 Elevance Health, Inc. 036752103 05/13/2026 Election of Directors: Deanna D. Strable DIRECTOR ELECTIONS ISSUER 1879405.000000 0.000000 FOR 1879405.000000 FOR S000002922 Elevance Health, Inc. 036752103 05/13/2026 Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 1879405.000000 0.000000 FOR 1879405.000000 FOR S000002922 Elevance Health, Inc. 036752103 05/13/2026 Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 1879405.000000 0.000000 FOR 1879405.000000 FOR 1 S000002922 Elevance Health, Inc. 036752103 05/13/2026 Ratification of Ernst & Young LLP as Auditors for 2026. AUDIT-RELATED ISSUER 1879405.000000 0.000000 FOR 1879405.000000 FOR S000002922 Elevance Health, Inc. 036752103 05/13/2026 Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. OTHER SOCIAL ISSUES SECURITY HOLDER 1879405.000000 0.000000 AGAINST 1879405.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Sangeeta Bhatia DIRECTOR ELECTIONS ISSUER 1628581.000000 0.000000 FOR 1628581.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Lloyd A. Carney DIRECTOR ELECTIONS ISSUER 1628581.000000 0.000000 FOR 1628581.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Alan Garber DIRECTOR ELECTIONS ISSUER 1628581.000000 0.000000 FOR 1628581.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Reshma Kewalramani DIRECTOR ELECTIONS ISSUER 1628581.000000 0.000000 FOR 1628581.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Michel Lagarde DIRECTOR ELECTIONS ISSUER 1628581.000000 0.000000 FOR 1628581.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Jeffrey Leiden DIRECTOR ELECTIONS ISSUER 1628581.000000 0.000000 FOR 1628581.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Diana McKenzie DIRECTOR ELECTIONS ISSUER 1628581.000000 0.000000 FOR 1628581.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Bruce Sachs DIRECTOR ELECTIONS ISSUER 1628581.000000 0.000000 FOR 1628581.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Jennifer Schneider DIRECTOR ELECTIONS ISSUER 1628581.000000 0.000000 FOR 1628581.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Nancy Thornberry DIRECTOR ELECTIONS ISSUER 1628581.000000 0.000000 FOR 1628581.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Suketu Upadhyay DIRECTOR ELECTIONS ISSUER 1628581.000000 0.000000 FOR 1628581.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1628581.000000 0.000000 FOR 1628581.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1628581.000000 0.000000 FOR 1628581.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1628581.000000 0.000000 FOR 1628581.000000 FOR 1 S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Approval of 2026 Stock and Option Plan. COMPENSATION ISSUER 1628581.000000 0.000000 FOR 1628581.000000 FOR S000002922 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 1628581.000000 0.000000 FOR 1628581.000000 AGAINST S000002922 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Fernando Aguirre DIRECTOR ELECTIONS ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Jeffrey R. Balser, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Election of Directors: C. David Brown II DIRECTOR ELECTIONS ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Alecia A. DeCoudreaux DIRECTOR ELECTIONS ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Anne M. Finucane DIRECTOR ELECTIONS ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Election of Directors: John E. Gallina DIRECTOR ELECTIONS ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Election of Directors: J. David Joyner DIRECTOR ELECTIONS ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Election of Directors: J. Scott Kirby DIRECTOR ELECTIONS ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Larry M. Robbins DIRECTOR ELECTIONS ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Douglas H. Shulman DIRECTOR ELECTIONS ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR 1 S000002922 CVS Health Corporation 126650100 05/14/2026 Proposal to Approve the Company's 2026 Incentive Compensation Plan. COMPENSATION ISSUER 9756578.000000 0.000000 FOR 9756578.000000 FOR S000002922 CVS Health Corporation 126650100 05/14/2026 Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 9756578.000000 0.000000 AGAINST 9756578.000000 FOR S000002922 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 Election of Class I Directors of Alnylam to serve for a term ending in 2029: Stuart A. Arbuckle DIRECTOR ELECTIONS ISSUER 1611791.000000 0.000000 FOR 1611791.000000 FOR S000002922 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 Election of Class I Directors of Alnylam to serve for a term ending in 2029: Yvonne L. Greenstreet, M.D. DIRECTOR ELECTIONS ISSUER 1611791.000000 0.000000 FOR 1611791.000000 FOR S000002922 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 Election of Class I Directors of Alnylam to serve for a term ending in 2029: Elliott Sigal M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1611791.000000 0.000000 FOR 1611791.000000 FOR S000002922 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1611791.000000 0.000000 FOR 1611791.000000 FOR S000002922 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1611791.000000 0.000000 FOR 1611791.000000 FOR 1 S000002922 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1611791.000000 0.000000 FOR 1611791.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/20/2026 Elect Elizabeth D. Bierbower DIRECTOR ELECTIONS ISSUER 5635025.000000 0.000000 FOR 5635025.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/20/2026 Elect Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 5635025.000000 0.000000 FOR 5635025.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/20/2026 Elect Eric K. Brandt DIRECTOR ELECTIONS ISSUER 5635025.000000 0.000000 FOR 5635025.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/20/2026 Elect Natasha Deckmann DIRECTOR ELECTIONS ISSUER 5635025.000000 0.000000 FOR 5635025.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/20/2026 Elect Harry M. Jansen Kraemer, Jr. DIRECTOR ELECTIONS ISSUER 5635025.000000 0.000000 FOR 5635025.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/20/2026 Elect R. Carter Pate DIRECTOR ELECTIONS ISSUER 5635025.000000 0.000000 FOR 5635025.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/20/2026 Elect John C. Rademacher DIRECTOR ELECTIONS ISSUER 5635025.000000 0.000000 FOR 5635025.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/20/2026 Elect Timothy P. Sullivan DIRECTOR ELECTIONS ISSUER 5635025.000000 0.000000 FOR 5635025.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/20/2026 Elect Norman L. Wright DIRECTOR ELECTIONS ISSUER 5635025.000000 0.000000 FOR 5635025.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/20/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 5635025.000000 0.000000 FOR 5635025.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/20/2026 To approve, on a non-binding advisory basis, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 5635025.000000 0.000000 FOR 5635025.000000 FOR S000002922 Option Care Health, Inc. 68404L201 05/20/2026 To approve, on a non-binding advisory basis, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 5635025.000000 0.000000 FOR 5635025.000000 FOR 1 S000002922 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Marc N. Casper DIRECTOR ELECTIONS ISSUER 584227.000000 0.000000 FOR 584227.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Nelson J. Chai DIRECTOR ELECTIONS ISSUER 584227.000000 0.000000 FOR 584227.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Ruby R. Chandy DIRECTOR ELECTIONS ISSUER 584227.000000 0.000000 FOR 584227.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: C. Martin Harris DIRECTOR ELECTIONS ISSUER 584227.000000 0.000000 FOR 584227.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Tyler Jacks DIRECTOR ELECTIONS ISSUER 584227.000000 0.000000 FOR 584227.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Jennifer M. Johnson DIRECTOR ELECTIONS ISSUER 584227.000000 0.000000 FOR 584227.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: R. Alexandra Keith DIRECTOR ELECTIONS ISSUER 584227.000000 0.000000 FOR 584227.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Karen S. Lynch DIRECTOR ELECTIONS ISSUER 584227.000000 0.000000 FOR 584227.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Debora L. Spar DIRECTOR ELECTIONS ISSUER 584227.000000 0.000000 FOR 584227.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Scott M. Sperling DIRECTOR ELECTIONS ISSUER 584227.000000 0.000000 FOR 584227.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Dion J. Weisler DIRECTOR ELECTIONS ISSUER 584227.000000 0.000000 FOR 584227.000000 FOR S000002922 Thermo Fisher Scientific Inc. 883556102 05/20/2026 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 584227.000000 0.000000 AGAINST 584227.000000 AGAINST S000002922 Thermo Fisher Scientific Inc. 883556102 05/20/2026 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 584227.000000 0.000000 AGAINST 584227.000000 AGAINST 1 S000002922 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2026. AUDIT-RELATED ISSUER 584227.000000 0.000000 FOR 584227.000000 FOR S000002922 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Sujay Kango DIRECTOR ELECTIONS ISSUER 1460509.000000 0.000000 FOR 1460509.000000 FOR S000002922 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorge DIRECTOR ELECTIONS ISSUER 1460509.000000 0.000000 FOR 1460509.000000 FOR S000002922 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Jonathan Violin, Ph.D. DIRECTOR ELECTIONS ISSUER 1460509.000000 0.000000 FOR 1460509.000000 FOR S000002922 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To approve, on an advisory basis, the compensation paid to our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 1460509.000000 0.000000 FOR 1460509.000000 FOR S000002922 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To approve, on an advisory basis, the compensation paid to our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 1460509.000000 0.000000 FOR 1460509.000000 FOR 1 S000002922 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1460509.000000 0.000000 FOR 1460509.000000 FOR S000002922 Mineralys Therapeutics, Inc. 603170101 05/21/2026 Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1858489.000000 0.000000 FOR 1858489.000000 FOR S000002922 Mineralys Therapeutics, Inc. 603170101 05/21/2026 Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Brian Taylor Slingsby, M.D., Ph.D., M.P.H. DIRECTOR ELECTIONS ISSUER 1858489.000000 0.000000 FOR 1858489.000000 FOR S000002922 Mineralys Therapeutics, Inc. 603170101 05/21/2026 Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Daphne Karydas DIRECTOR ELECTIONS ISSUER 1858489.000000 0.000000 FOR 1858489.000000 FOR S000002922 Mineralys Therapeutics, Inc. 603170101 05/21/2026 Ratify the appointment of Ernst & Young LLP as Mineralys Therapeutics, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1858489.000000 0.000000 FOR 1858489.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Douglas M. Baker, Jr. DIRECTOR ELECTIONS ISSUER 17789747.000000 0.000000 FOR 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Mary Ellen Coe DIRECTOR ELECTIONS ISSUER 17789747.000000 0.000000 FOR 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Pamela J. Craig DIRECTOR ELECTIONS ISSUER 17789747.000000 0.000000 FOR 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Robert M. Davis DIRECTOR ELECTIONS ISSUER 17789747.000000 0.000000 FOR 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Thomas H. Glocer DIRECTOR ELECTIONS ISSUER 17789747.000000 0.000000 FOR 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Surendralal L. Karsanbhai DIRECTOR ELECTIONS ISSUER 17789747.000000 0.000000 FOR 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Risa J. Lavizzo-Mourey, M.D. DIRECTOR ELECTIONS ISSUER 17789747.000000 0.000000 FOR 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Stephen L. Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 17789747.000000 0.000000 FOR 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 17789747.000000 0.000000 FOR 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Patrick F. Russo DIRECTOR ELECTIONS ISSUER 17789747.000000 0.000000 AGAINST 17789747.000000 AGAINST S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Christine E. Seidman, M.D. DIRECTOR ELECTIONS ISSUER 17789747.000000 0.000000 FOR 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Inge G. Thulin DIRECTOR ELECTIONS ISSUER 17789747.000000 0.000000 FOR 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Kathy J. Warden DIRECTOR ELECTIONS ISSUER 17789747.000000 0.000000 FOR 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 17789747.000000 0.000000 FOR 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 17789747.000000 0.000000 FOR 17789747.000000 FOR 1 S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Ratification of the appointment of the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 17789747.000000 0.000000 FOR 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Shareholder proposal regarding a report on DEI risks in federal contracting. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 17789747.000000 0.000000 AGAINST 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Shareholder proposal regarding a report on healthcare coverage gaps. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 17789747.000000 0.000000 AGAINST 17789747.000000 FOR S000002922 Merck & Co., Inc. 58933Y105 05/26/2026 Shareholder proposal regarding a report on political contributions. OTHER SOCIAL ISSUES SECURITY HOLDER 17789747.000000 0.000000 AGAINST 17789747.000000 FOR S000002922 Cytokinetics, Incorporated 23282W605 05/27/2026 Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D. DIRECTOR ELECTIONS ISSUER 4064763.000000 0.000000 FOR 4064763.000000 FOR S000002922 Cytokinetics, Incorporated 23282W605 05/27/2026 Election of Class I Directors for terms expiring in 2029: Wendell Wierenga, Ph.D. DIRECTOR ELECTIONS ISSUER 4064763.000000 0.000000 FOR 4064763.000000 FOR S000002922 Cytokinetics, Incorporated 23282W605 05/27/2026 Election of Class I Directors for terms expiring in 2029: Nancy J. Wysenski DIRECTOR ELECTIONS ISSUER 4064763.000000 0.000000 FOR 4064763.000000 FOR S000002922 Cytokinetics, Incorporated 23282W605 05/27/2026 To approve the amendment and restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of authorized shares reserved for issuance thereunder by 1,000,000 shares of common stock. COMPENSATION ISSUER 4064763.000000 0.000000 FOR 4064763.000000 FOR S000002922 Cytokinetics, Incorporated 23282W605 05/27/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4064763.000000 0.000000 FOR 4064763.000000 FOR S000002922 Cytokinetics, Incorporated 23282W605 05/27/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4064763.000000 0.000000 FOR 4064763.000000 FOR S000002922 Cytokinetics, Incorporated 23282W605 05/27/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4064763.000000 0.000000 FOR 4064763.000000 FOR 1 S000002922 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Steven Altman DIRECTOR ELECTIONS ISSUER 6062352.000000 0.000000 FOR 6062352.000000 FOR S000002922 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Dr. Euan Ashley DIRECTOR ELECTIONS ISSUER 6062352.000000 0.000000 FOR 6062352.000000 FOR S000002922 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Nicholas Augustinos DIRECTOR ELECTIONS ISSUER 6062352.000000 0.000000 FOR 6062352.000000 FOR S000002922 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Richard Collins DIRECTOR ELECTIONS ISSUER 6062352.000000 0.000000 FOR 6062352.000000 FOR S000002922 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Rimma Driscoll DIRECTOR ELECTIONS ISSUER 6062352.000000 0.000000 FOR 6062352.000000 FOR S000002922 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Mark Foletta DIRECTOR ELECTIONS ISSUER 6062352.000000 0.000000 FOR 6062352.000000 FOR S000002922 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Renee Gala DIRECTOR ELECTIONS ISSUER 6062352.000000 0.000000 FOR 6062352.000000 FOR S000002922 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Bridgette Heller DIRECTOR ELECTIONS ISSUER 6062352.000000 0.000000 FOR 6062352.000000 FOR S000002922 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Jacob Leach DIRECTOR ELECTIONS ISSUER 6062352.000000 0.000000 FOR 6062352.000000 FOR S000002922 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Kyle Malady DIRECTOR ELECTIONS ISSUER 6062352.000000 0.000000 FOR 6062352.000000 FOR S000002922 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Rick Osterloh DIRECTOR ELECTIONS ISSUER 6062352.000000 0.000000 FOR 6062352.000000 FOR S000002922 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Kevin Sayer DIRECTOR ELECTIONS ISSUER 6062352.000000 0.000000 FOR 6062352.000000 FOR S000002922 DexCom, Inc. 252131107 05/27/2026 To ratify the selection by the Audit Committee of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 6062352.000000 0.000000 FOR 6062352.000000 FOR S000002922 DexCom, Inc. 252131107 05/27/2026 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 6062352.000000 0.000000 FOR 6062352.000000 FOR S000002922 DexCom, Inc. 252131107 05/27/2026 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 6062352.000000 0.000000 FOR 6062352.000000 FOR 1 S000002922 Immunocore Holdings plc 45258D105 05/27/2026 To re-appoint Siddharth Kaul as a director who retires in accordance with the articles of association. DIRECTOR ELECTIONS ISSUER 2798908.000000 858900.000000 FOR 2798908.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/27/2026 To re-appoint William Pao, M.D., Ph.D. as a director who retires in accordance with the articles of association. DIRECTOR ELECTIONS ISSUER 2798908.000000 858900.000000 FOR 2798908.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/27/2026 To re-appoint Kristine Peterson as a director who retires in accordance with the articles of association. DIRECTOR ELECTIONS ISSUER 2798908.000000 858900.000000 FOR 2798908.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/27/2026 To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2798908.000000 858900.000000 FOR 2798908.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/27/2026 To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2798908.000000 858900.000000 FOR 2798908.000000 FOR 1 S000002922 Immunocore Holdings plc 45258D105 05/27/2026 To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending 31 December 2026. AUDIT-RELATED ISSUER 2798908.000000 858900.000000 FOR 2798908.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/27/2026 To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. AUDIT-RELATED ISSUER 2798908.000000 858900.000000 FOR 2798908.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/27/2026 To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending 31 December 2026. AUDIT-RELATED ISSUER 2798908.000000 858900.000000 FOR 2798908.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/27/2026 To receive and adopt the U.K. statutory annual accounts and reports for the year ended 31 December 2025. CORPORATE GOVERNANCE ISSUER 2798908.000000 858900.000000 FOR 2798908.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/27/2026 To approve our directors' remuneration report for the year ended December 31, 2025, which is set forth as Annex A to the attached proxy statement and on pages 26 to 56 of the 2025 U.K. Annual Report (excluding the directors' remuneration policy set out on 26 to 56 2025 U.K. Annual Report (excluding the directors' remuneration policy set out on A7 to A18 of Annex A). COMPENSATION ISSUER 2798908.000000 858900.000000 FOR 2798908.000000 FOR S000002922 Immunocore Holdings plc 45258D105 05/27/2026 To authorize the Company and all of its subsidiaries to make political donations and incur political expenditure. OTHER SOCIAL ISSUES ISSUER 2798908.000000 858900.000000 FOR 2798908.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/29/2026 Accounts and Reports CORPORATE GOVERNANCE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/29/2026 Directors' Report CORPORATE GOVERNANCE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/29/2026 Supervisors' Report CORPORATE GOVERNANCE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/29/2026 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/29/2026 Appointment of Auditor and Authority to Set Fees AUDIT-RELATED ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/29/2026 Directors' Fees COMPENSATION ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/29/2026 Authority to Issue H Shares and/or Domestic Shares w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 Shandong Weigao Group Medical Polymer Company Limited CNE100000171 05/29/2026 Authority to Repurchase H Shares CAPITAL STRUCTURE ISSUER 77092000.000000 0.000000 FOR 77092000.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Charles Baker DIRECTOR ELECTIONS ISSUER 3947604.000000 0.000000 FOR 3947604.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Timothy Flynn DIRECTOR ELECTIONS ISSUER 3947604.000000 0.000000 FOR 3947604.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Paul Garcia DIRECTOR ELECTIONS ISSUER 3947604.000000 0.000000 FOR 3947604.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Kristen Gil DIRECTOR ELECTIONS ISSUER 3947604.000000 0.000000 FOR 3947604.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 3947604.000000 0.000000 FOR 3947604.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Stephen Hemsley DIRECTOR ELECTIONS ISSUER 3947604.000000 0.000000 FOR 3947604.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. F. William McNabb III DIRECTOR ELECTIONS ISSUER 3947604.000000 0.000000 FOR 3947604.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Valerie Montgomery Rice, M.D. DIRECTOR ELECTIONS ISSUER 3947604.000000 0.000000 FOR 3947604.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. John Noseworthy, M.D. DIRECTOR ELECTIONS ISSUER 3947604.000000 0.000000 FOR 3947604.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/01/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3947604.000000 0.000000 FOR 3947604.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/01/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3947604.000000 0.000000 FOR 3947604.000000 FOR 1 S000002922 UnitedHealth Group Incorporated 91324P102 06/01/2026 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 3947604.000000 0.000000 FOR 3947604.000000 FOR S000002922 UnitedHealth Group Incorporated 91324P102 06/01/2026 If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. CORPORATE GOVERNANCE SECURITY HOLDER 3947604.000000 0.000000 AGAINST 3947604.000000 FOR S000002922 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Adoption of the Dutch statutory annual accounts for the fiscal year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 3065323.000000 360500.000000 FOR 3065323.000000 FOR S000002922 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Discharge from liability for the Company's directors with respect to the performance of their duties during the fiscal year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 3065323.000000 360500.000000 FOR 3065323.000000 FOR S000002922 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Instruction to Deloitte Accountants B.V. as the Company's external auditor of the Company's Dutch statutory annual accounts and Dutch statutory board report for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3065323.000000 360500.000000 FOR 3065323.000000 FOR S000002922 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Ratification of the selection of Deloitte Accountants B.V. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 by the audit committee of the Company's Board of Directors. AUDIT-RELATED ISSUER 3065323.000000 360500.000000 FOR 3065323.000000 FOR S000002922 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name. John W. Smither until the 2030 annual general meeting DIRECTOR ELECTIONS ISSUER 3065323.000000 360500.000000 FOR 3065323.000000 FOR S000002922 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name. Janneke van der Kamp until the 2030 annual general meeting DIRECTOR ELECTIONS ISSUER 3065323.000000 360500.000000 FOR 3065323.000000 FOR S000002922 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Extension of authorization for the Board of Directors to issue ordinary shares (or rights to subscribe for ordinary shares) in the Company's capital. CAPITAL STRUCTURE ISSUER 3065323.000000 360500.000000 AGAINST 3065323.000000 AGAINST S000002922 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Extension of authorization for the Board of Directors to limit or exclude pre-emption rights. CAPITAL STRUCTURE ISSUER 3065323.000000 360500.000000 AGAINST 3065323.000000 AGAINST S000002922 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Approval of the NewAmsterdam Pharma Company N.V. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 3065323.000000 360500.000000 FOR 3065323.000000 FOR S000002922 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Non-binding, advisory vote to approve the 2025 compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3065323.000000 360500.000000 FOR 3065323.000000 FOR S000002922 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Non-binding, advisory vote to approve the 2025 compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3065323.000000 360500.000000 FOR 3065323.000000 FOR 1 S000002922 PTC Therapeutics, Inc. 69366J200 06/02/2026 Elect Jessica Chutter DIRECTOR ELECTIONS ISSUER 2038232.000000 0.000000 FOR 2038232.000000 FOR S000002922 PTC Therapeutics, Inc. 69366J200 06/02/2026 Elect Matthew B. Klein DIRECTOR ELECTIONS ISSUER 2038232.000000 0.000000 FOR 2038232.000000 FOR S000002922 PTC Therapeutics, Inc. 69366J200 06/02/2026 Elect Stephanie S. Okey DIRECTOR ELECTIONS ISSUER 2038232.000000 0.000000 FOR 2038232.000000 FOR S000002922 PTC Therapeutics, Inc. 69366J200 06/02/2026 Elect Jerome B. Zeldis DIRECTOR ELECTIONS ISSUER 2038232.000000 0.000000 FOR 2038232.000000 FOR S000002922 PTC Therapeutics, Inc. 69366J200 06/02/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2038232.000000 0.000000 FOR 2038232.000000 FOR S000002922 PTC Therapeutics, Inc. 69366J200 06/02/2026 Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2038232.000000 0.000000 FOR 2038232.000000 FOR S000002922 PTC Therapeutics, Inc. 69366J200 06/02/2026 Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2038232.000000 0.000000 FOR 2038232.000000 FOR 1 S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Dawn Svoronos DIRECTOR ELECTIONS ISSUER 3214968.000000 0.000000 FOR 3214968.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gillian M. Cannon DIRECTOR ELECTIONS ISSUER 3214968.000000 0.000000 FOR 3214968.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Steven Gannon DIRECTOR ELECTIONS ISSUER 3214968.000000 0.000000 FOR 3214968.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Elizabeth A. Garofalo DIRECTOR ELECTIONS ISSUER 3214968.000000 0.000000 FOR 3214968.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Justin Gover DIRECTOR ELECTIONS ISSUER 3214968.000000 0.000000 FOR 3214968.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Patrick Machado DIRECTOR ELECTIONS ISSUER 3214968.000000 0.000000 FOR 3214968.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Ian Mortimer DIRECTOR ELECTIONS ISSUER 3214968.000000 0.000000 FOR 3214968.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gary Patou DIRECTOR ELECTIONS ISSUER 3214968.000000 0.000000 FOR 3214968.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To approve, on an advisory basis, the compensation of the Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3214968.000000 0.000000 FOR 3214968.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To approve, on an advisory basis, the compensation of the Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3214968.000000 0.000000 FOR 3214968.000000 FOR 1 S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3214968.000000 0.000000 ONE YEAR 3214968.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3214968.000000 0.000000 ONE YEAR 3214968.000000 FOR 1 S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To approve the Corporation's 2026 Equity Incentive Plan. COMPENSATION ISSUER 3214968.000000 0.000000 FOR 3214968.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To appoint PricewaterhouseCoopers LLP as the Corporation's auditor to hold office until the next annual meeting of the Corporation. AUDIT-RELATED ISSUER 3214968.000000 0.000000 FOR 3214968.000000 FOR S000002922 Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditors of the Corporation. AUDIT-RELATED ISSUER 3214968.000000 0.000000 FOR 3214968.000000 FOR S000002922 Stoke Therapeutics, Inc 86150R107 06/03/2026 Elect Clare Kahn DIRECTOR ELECTIONS ISSUER 1652492.000000 0.000000 FOR 1652492.000000 FOR S000002922 Stoke Therapeutics, Inc 86150R107 06/03/2026 Elect Adrian R. Krainer DIRECTOR ELECTIONS ISSUER 1652492.000000 0.000000 FOR 1652492.000000 FOR S000002922 Stoke Therapeutics, Inc 86150R107 06/03/2026 Elect Julie Anne Smith DIRECTOR ELECTIONS ISSUER 1652492.000000 0.000000 FOR 1652492.000000 FOR S000002922 Stoke Therapeutics, Inc 86150R107 06/03/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1652492.000000 0.000000 FOR 1652492.000000 FOR S000002922 Stoke Therapeutics, Inc 86150R107 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1652492.000000 0.000000 FOR 1652492.000000 FOR S000002922 Stoke Therapeutics, Inc 86150R107 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1652492.000000 0.000000 FOR 1652492.000000 FOR 1 S000002922 Alignment Healthcare, Inc. 01625V104 06/04/2026 Election of Directors: Jody Bilney DIRECTOR ELECTIONS ISSUER 8043737.000000 0.000000 FOR 8043737.000000 FOR S000002922 Alignment Healthcare, Inc. 01625V104 06/04/2026 Election of Directors: David Hodgson DIRECTOR ELECTIONS ISSUER 8043737.000000 0.000000 FOR 8043737.000000 FOR S000002922 Alignment Healthcare, Inc. 01625V104 06/04/2026 Election of Directors: Jacqueline Kosecoff DIRECTOR ELECTIONS ISSUER 8043737.000000 0.000000 FOR 8043737.000000 FOR S000002922 Alignment Healthcare, Inc. 01625V104 06/04/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026 AUDIT-RELATED ISSUER 8043737.000000 0.000000 FOR 8043737.000000 FOR S000002922 Alignment Healthcare, Inc. 01625V104 06/04/2026 Approval, on a non-binding, advisory basis, of the compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 8043737.000000 0.000000 FOR 8043737.000000 FOR S000002922 Alignment Healthcare, Inc. 01625V104 06/04/2026 Approval, on a non-binding, advisory basis, of the compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 8043737.000000 0.000000 FOR 8043737.000000 FOR 1 S000002922 CG Oncology, Inc. 156944100 06/04/2026 To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Christina Rossi DIRECTOR ELECTIONS ISSUER 2861712.000000 0.000000 FOR 2861712.000000 FOR S000002922 CG Oncology, Inc. 156944100 06/04/2026 To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Victor Tong, Jr. DIRECTOR ELECTIONS ISSUER 2861712.000000 0.000000 FOR 2861712.000000 FOR S000002922 CG Oncology, Inc. 156944100 06/04/2026 To ratify the appointment by the Audit Committee of the Board of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2861712.000000 0.000000 FOR 2861712.000000 FOR S000002922 CG Oncology, Inc. 156944100 06/04/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2861712.000000 0.000000 FOR 2861712.000000 FOR S000002922 CG Oncology, Inc. 156944100 06/04/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2861712.000000 0.000000 FOR 2861712.000000 FOR 1 S000002922 CG Oncology, Inc. 156944100 06/04/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2861712.000000 0.000000 ONE YEAR 2861712.000000 FOR S000002922 CG Oncology, Inc. 156944100 06/04/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2861712.000000 0.000000 ONE YEAR 2861712.000000 FOR 1 S000002922 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 Election of Directors Nominees Spencer R. Berthelsen DIRECTOR ELECTIONS ISSUER 3803181.000000 0.000000 FOR 3803181.000000 FOR S000002922 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 Election of Directors Nominees Joan E. Herman DIRECTOR ELECTIONS ISSUER 3803181.000000 0.000000 FOR 3803181.000000 FOR S000002922 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 To make an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3803181.000000 0.000000 FOR 3803181.000000 FOR S000002922 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 To make an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3803181.000000 0.000000 FOR 3803181.000000 FOR 1 S000002922 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 To approve an amendment of the Amended and Restated Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 9,500,000 shares to an aggregate of 52,000,000 shares. COMPENSATION ISSUER 3803181.000000 0.000000 FOR 3803181.000000 FOR S000002922 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 To approve an amendment of the Amended and Restated 2000 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for purchase under such plan by 750,000 shares and remove the termination date of the plan. COMPENSATION ISSUER 3803181.000000 0.000000 FOR 3803181.000000 FOR S000002922 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 To ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2026 fiscal year. AUDIT-RELATED ISSUER 3803181.000000 0.000000 FOR 3803181.000000 FOR S000002922 Scholar Rock Holding Corporation 80706P103 06/04/2026 Elect David Hallal DIRECTOR ELECTIONS ISSUER 3466533.000000 0.000000 FOR 3466533.000000 FOR S000002922 Scholar Rock Holding Corporation 80706P103 06/04/2026 Elect Kristina M. Burow DIRECTOR ELECTIONS ISSUER 3466533.000000 0.000000 FOR 3466533.000000 FOR S000002922 Scholar Rock Holding Corporation 80706P103 06/04/2026 Elect Michael Gilman DIRECTOR ELECTIONS ISSUER 3466533.000000 0.000000 FOR 3466533.000000 FOR S000002922 Scholar Rock Holding Corporation 80706P103 06/04/2026 Elect Katie Peng DIRECTOR ELECTIONS ISSUER 3466533.000000 0.000000 FOR 3466533.000000 FOR S000002922 Scholar Rock Holding Corporation 80706P103 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3466533.000000 0.000000 FOR 3466533.000000 FOR S000002922 Scholar Rock Holding Corporation 80706P103 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3466533.000000 0.000000 FOR 3466533.000000 FOR S000002922 Scholar Rock Holding Corporation 80706P103 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3466533.000000 0.000000 FOR 3466533.000000 FOR 1 S000002922 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Julian C. Baker DIRECTOR ELECTIONS ISSUER 2365620.000000 0.000000 AGAINST 2365620.000000 AGAINST S000002922 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 2365620.000000 0.000000 FOR 2365620.000000 FOR S000002922 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Otis W. Brawley DIRECTOR ELECTIONS ISSUER 2365620.000000 0.000000 FOR 2365620.000000 FOR S000002922 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Paul J. Clancy DIRECTOR ELECTIONS ISSUER 2365620.000000 0.000000 FOR 2365620.000000 FOR S000002922 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Jacqualyn A. Fouse DIRECTOR ELECTIONS ISSUER 2365620.000000 0.000000 FOR 2365620.000000 FOR S000002922 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Edmund P. Harrigan DIRECTOR ELECTIONS ISSUER 2365620.000000 0.000000 FOR 2365620.000000 FOR S000002922 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Katherine A. High DIRECTOR ELECTIONS ISSUER 2365620.000000 0.000000 FOR 2365620.000000 FOR S000002922 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: William J. Meury DIRECTOR ELECTIONS ISSUER 2365620.000000 0.000000 FOR 2365620.000000 FOR S000002922 Incyte Corporation 45337C102 06/08/2026 Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2365620.000000 0.000000 FOR 2365620.000000 FOR S000002922 Incyte Corporation 45337C102 06/08/2026 Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2365620.000000 0.000000 FOR 2365620.000000 FOR 1 S000002922 Incyte Corporation 45337C102 06/08/2026 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2365620.000000 0.000000 FOR 2365620.000000 FOR S000002922 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Elect Mark C. McKenna DIRECTOR ELECTIONS ISSUER 1828017.000000 0.000000 FOR 1828017.000000 FOR S000002922 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Elect Jennifer Fox DIRECTOR ELECTIONS ISSUER 1828017.000000 0.000000 FOR 1828017.000000 FOR S000002922 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Elect William Jones, Jr. DIRECTOR ELECTIONS ISSUER 1828017.000000 0.000000 FOR 1828017.000000 FOR S000002922 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1828017.000000 0.000000 FOR 1828017.000000 FOR S000002922 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1828017.000000 0.000000 FOR 1828017.000000 FOR S000002922 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1828017.000000 0.000000 FOR 1828017.000000 FOR 1 S000002922 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire DIRECTOR ELECTIONS ISSUER 2621678.000000 0.000000 FOR 2621678.000000 FOR S000002922 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins DIRECTOR ELECTIONS ISSUER 2621678.000000 0.000000 FOR 2621678.000000 FOR S000002922 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer DIRECTOR ELECTIONS ISSUER 2621678.000000 0.000000 FOR 2621678.000000 FOR S000002922 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas DIRECTOR ELECTIONS ISSUER 2621678.000000 0.000000 FOR 2621678.000000 FOR S000002922 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd B. Minor DIRECTOR ELECTIONS ISSUER 2621678.000000 0.000000 FOR 2621678.000000 FOR S000002922 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Menelas Pangalos DIRECTOR ELECTIONS ISSUER 2621678.000000 0.000000 FOR 2621678.000000 FOR S000002922 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala DIRECTOR ELECTIONS ISSUER 2621678.000000 0.000000 FOR 2621678.000000 FOR S000002922 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky DIRECTOR ELECTIONS ISSUER 2621678.000000 0.000000 FOR 2621678.000000 FOR S000002922 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin DIRECTOR ELECTIONS ISSUER 2621678.000000 0.000000 FOR 2621678.000000 FOR S000002922 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher DIRECTOR ELECTIONS ISSUER 2621678.000000 0.000000 FOR 2621678.000000 FOR S000002922 Biogen Inc. 09062X103 06/09/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2621678.000000 0.000000 FOR 2621678.000000 FOR S000002922 Biogen Inc. 09062X103 06/09/2026 Say on Pay - To hold an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2621678.000000 0.000000 FOR 2621678.000000 FOR S000002922 Biogen Inc. 09062X103 06/09/2026 Say on Pay - To hold an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2621678.000000 0.000000 FOR 2621678.000000 FOR 1 S000002922 Immunome, Inc. 45257U108 06/09/2026 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal. James Boylan DIRECTOR ELECTIONS ISSUER 2776580.000000 0.000000 FOR 2776580.000000 FOR S000002922 Immunome, Inc. 45257U108 06/09/2026 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal. Sandra M. Swain, M.D. DIRECTOR ELECTIONS ISSUER 2776580.000000 0.000000 FOR 2776580.000000 FOR S000002922 Immunome, Inc. 45257U108 06/09/2026 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal. Philip Wagenheim DIRECTOR ELECTIONS ISSUER 2776580.000000 0.000000 FOR 2776580.000000 FOR S000002922 Immunome, Inc. 45257U108 06/09/2026 To ratify the appointment of Ernst & Young LLP our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2776580.000000 0.000000 FOR 2776580.000000 FOR S000002922 Immunome, Inc. 45257U108 06/09/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2776580.000000 0.000000 FOR 2776580.000000 FOR S000002922 Immunome, Inc. 45257U108 06/09/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2776580.000000 0.000000 FOR 2776580.000000 FOR 1 S000002922 Immunome, Inc. 45257U108 06/09/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2776580.000000 0.000000 ONE YEAR 2776580.000000 FOR S000002922 Immunome, Inc. 45257U108 06/09/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2776580.000000 0.000000 ONE YEAR 2776580.000000 FOR 1 S000002922 Arcus Biosciences, Inc. 03969F109 06/11/2026 Election of Directors: Dietmar Berger, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 4124859.000000 0.000000 FOR 4124859.000000 FOR S000002922 Arcus Biosciences, Inc. 03969F109 06/11/2026 Election of Directors: David Lacey, M.D. DIRECTOR ELECTIONS ISSUER 4124859.000000 0.000000 FOR 4124859.000000 FOR S000002922 Arcus Biosciences, Inc. 03969F109 06/11/2026 Election of Directors: Nicole Lambert DIRECTOR ELECTIONS ISSUER 4124859.000000 0.000000 FOR 4124859.000000 FOR S000002922 Arcus Biosciences, Inc. 03969F109 06/11/2026 Election of Directors: Johanna Mercier DIRECTOR ELECTIONS ISSUER 4124859.000000 0.000000 FOR 4124859.000000 FOR S000002922 Arcus Biosciences, Inc. 03969F109 06/11/2026 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4124859.000000 0.000000 FOR 4124859.000000 FOR S000002922 Arcus Biosciences, Inc. 03969F109 06/11/2026 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4124859.000000 0.000000 FOR 4124859.000000 FOR S000002922 Arcus Biosciences, Inc. 03969F109 06/11/2026 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4124859.000000 0.000000 FOR 4124859.000000 FOR 1 S000002922 Natera, Inc. 632307104 06/11/2026 Elect Rowan Chapman DIRECTOR ELECTIONS ISSUER 559042.000000 0.000000 FOR 559042.000000 FOR S000002922 Natera, Inc. 632307104 06/11/2026 Elect Herm Rosenman DIRECTOR ELECTIONS ISSUER 559042.000000 0.000000 FOR 559042.000000 FOR S000002922 Natera, Inc. 632307104 06/11/2026 Elect Jonathan Sheena DIRECTOR ELECTIONS ISSUER 559042.000000 0.000000 FOR 559042.000000 FOR S000002922 Natera, Inc. 632307104 06/11/2026 Elect Eric H. Rubin DIRECTOR ELECTIONS ISSUER 559042.000000 0.000000 FOR 559042.000000 FOR S000002922 Natera, Inc. 632307104 06/11/2026 To ratify the appointment of Ernst & Young LLP as Natera, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 559042.000000 0.000000 FOR 559042.000000 FOR S000002922 Natera, Inc. 632307104 06/11/2026 To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 559042.000000 0.000000 FOR 559042.000000 FOR S000002922 Natera, Inc. 632307104 06/11/2026 To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 559042.000000 0.000000 FOR 559042.000000 FOR 1 S000002922 Natera, Inc. 632307104 06/11/2026 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 559042.000000 0.000000 ONE YEAR 559042.000000 FOR S000002922 Natera, Inc. 632307104 06/11/2026 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 559042.000000 0.000000 ONE YEAR 559042.000000 FOR 1 S000002922 Natera, Inc. 632307104 06/11/2026 To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated. COMPENSATION ISSUER 559042.000000 0.000000 FOR 559042.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Election of Directors: Joseph L. Goldstein, M.D. DIRECTOR ELECTIONS ISSUER 852112.000000 0.000000 FOR 852112.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Election of Directors: Christine A. Poon DIRECTOR ELECTIONS ISSUER 852112.000000 0.000000 FOR 852112.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Election of Directors: David P. Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 852112.000000 0.000000 FOR 852112.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Election of Directors: Craig B. Thompson, M.D. DIRECTOR ELECTIONS ISSUER 852112.000000 0.000000 FOR 852112.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Election of Directors: Huda Y. Zoghbi, M.D. DIRECTOR ELECTIONS ISSUER 852112.000000 0.000000 FOR 852112.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 852112.000000 0.000000 FOR 852112.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Proposal to approve, on an advisory basis, compensation of the Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 852112.000000 0.000000 FOR 852112.000000 FOR S000002922 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Proposal to approve, on an advisory basis, compensation of the Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 852112.000000 0.000000 FOR 852112.000000 FOR 1 S000002922 Vaxcyte, Inc. 92243G108 06/15/2026 Elect Olivier Brandicourt DIRECTOR ELECTIONS ISSUER 2667349.000000 0.000000 FOR 2667349.000000 FOR S000002922 Vaxcyte, Inc. 92243G108 06/15/2026 Elect Halley E. Gilbert DIRECTOR ELECTIONS ISSUER 2667349.000000 0.000000 FOR 2667349.000000 FOR S000002922 Vaxcyte, Inc. 92243G108 06/15/2026 Elect Grant E. Pickering DIRECTOR ELECTIONS ISSUER 2667349.000000 0.000000 FOR 2667349.000000 FOR S000002922 Vaxcyte, Inc. 92243G108 06/15/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2667349.000000 0.000000 FOR 2667349.000000 FOR S000002922 Vaxcyte, Inc. 92243G108 06/15/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2667349.000000 0.000000 FOR 2667349.000000 FOR S000002922 Vaxcyte, Inc. 92243G108 06/15/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2667349.000000 0.000000 FOR 2667349.000000 FOR 1 S000002922 HeartFlow, Inc. 42238D107 06/16/2026 Election of the two nominees as Class I directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Julie A. Cullivan DIRECTOR ELECTIONS ISSUER 5612221.000000 51100.000000 FOR 5612221.000000 FOR S000002922 HeartFlow, Inc. 42238D107 06/16/2026 Election of the two nominees as Class I directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: John C.M. Farquhar DIRECTOR ELECTIONS ISSUER 5612221.000000 51100.000000 FOR 5612221.000000 FOR S000002922 HeartFlow, Inc. 42238D107 06/16/2026 The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 5612221.000000 51100.000000 FOR 5612221.000000 FOR S000002922 Nuvalent, Inc. 670703107 06/16/2026 Election of the following nominees as Class Il directors: Michael L. Meyers, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 873258.000000 0.000000 FOR 873258.000000 FOR S000002922 Nuvalent, Inc. 670703107 06/16/2026 Election of the following nominees as Class Il directors: Ron Squarer DIRECTOR ELECTIONS ISSUER 873258.000000 0.000000 FOR 873258.000000 FOR S000002922 Nuvalent, Inc. 670703107 06/16/2026 To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 873258.000000 0.000000 FOR 873258.000000 FOR S000002922 Nuvalent, Inc. 670703107 06/16/2026 To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 873258.000000 0.000000 FOR 873258.000000 FOR 1 S000002922 Nuvalent, Inc. 670703107 06/16/2026 To ratify the appointment of KPMG LLP as Nuvalent, Inc. 's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 873258.000000 0.000000 FOR 873258.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/17/2026 Elect Haruo Naito DIRECTOR ELECTIONS ISSUER 8514317.000000 0.000000 FOR 8514317.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/17/2026 Elect Fumihiko Ike DIRECTOR ELECTIONS ISSUER 8514317.000000 0.000000 FOR 8514317.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/17/2026 Elect Hiroyuki Kato DIRECTOR ELECTIONS ISSUER 8514317.000000 0.000000 FOR 8514317.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/17/2026 Elect Richard Thornley DIRECTOR ELECTIONS ISSUER 8514317.000000 0.000000 FOR 8514317.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/17/2026 Elect Toru Moriyama DIRECTOR ELECTIONS ISSUER 8514317.000000 0.000000 FOR 8514317.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/17/2026 Elect Yuko Yasuda DIRECTOR ELECTIONS ISSUER 8514317.000000 0.000000 FOR 8514317.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/17/2026 Elect Takuji Kanai DIRECTOR ELECTIONS ISSUER 8514317.000000 0.000000 FOR 8514317.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/17/2026 Elect Kenta Takahashi DIRECTOR ELECTIONS ISSUER 8514317.000000 0.000000 FOR 8514317.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/17/2026 Elect Yasushi Okada DIRECTOR ELECTIONS ISSUER 8514317.000000 0.000000 FOR 8514317.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/17/2026 Elect Ryoko Ueda DIRECTOR ELECTIONS ISSUER 8514317.000000 0.000000 FOR 8514317.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/17/2026 Elect Koichi Kawana DIRECTOR ELECTIONS ISSUER 8514317.000000 0.000000 FOR 8514317.000000 FOR S000002922 Eisai Co., Ltd. JP3160400002 06/17/2026 Elect Yuko Toyoda DIRECTOR ELECTIONS ISSUER 8514317.000000 0.000000 FOR 8514317.000000 FOR S000002922 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Re-election of Class I directors: Julian Baker DIRECTOR ELECTIONS ISSUER 408918.000000 0.000000 WITHHOLD 408918.000000 AGAINST S000002922 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Re-election of Class I directors: Daniel Brennan DIRECTOR ELECTIONS ISSUER 408918.000000 0.000000 FOR 408918.000000 FOR S000002922 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Re-election of Class I directors: James Daly DIRECTOR ELECTIONS ISSUER 408918.000000 0.000000 FOR 408918.000000 FOR S000002922 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 408918.000000 0.000000 FOR 408918.000000 FOR S000002922 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 408918.000000 0.000000 FOR 408918.000000 FOR 1 S000002922 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 408918.000000 0.000000 FOR 408918.000000 FOR S000002922 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Approval of Madrigal Pharmaceuticals, Inc. 2026 Stock Plan COMPENSATION ISSUER 408918.000000 0.000000 FOR 408918.000000 FOR S000002922 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Approval of Madrigal Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan COMPENSATION ISSUER 408918.000000 0.000000 FOR 408918.000000 FOR S000002922 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 Elect Dinesh V. Patel DIRECTOR ELECTIONS ISSUER 1380445.000000 0.000000 FOR 1380445.000000 FOR S000002922 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 Elect Lewis T. Williams DIRECTOR ELECTIONS ISSUER 1380445.000000 0.000000 FOR 1380445.000000 FOR S000002922 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1380445.000000 0.000000 FOR 1380445.000000 FOR S000002922 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1380445.000000 0.000000 FOR 1380445.000000 FOR 1 S000002922 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1380445.000000 0.000000 FOR 1380445.000000 FOR S000002922 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 To approve the adoption of the Company's 2026 Equity Incentive Plan. COMPENSATION ISSUER 1380445.000000 0.000000 FOR 1380445.000000 FOR S000002922 Structure Therapeutics Inc. 86366E106 06/17/2026 Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Ted W. Love, M.D. DIRECTOR ELECTIONS ISSUER 2909218.000000 0.000000 FOR 2909218.000000 FOR S000002922 Structure Therapeutics Inc. 86366E106 06/17/2026 Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Raymond Stevens, Ph.D. DIRECTOR ELECTIONS ISSUER 2909218.000000 0.000000 FOR 2909218.000000 FOR S000002922 Structure Therapeutics Inc. 86366E106 06/17/2026 Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Daniel G. Welch DIRECTOR ELECTIONS ISSUER 2909218.000000 0.000000 FOR 2909218.000000 FOR S000002922 Structure Therapeutics Inc. 86366E106 06/17/2026 To ratify the appointment by the Audit Committee of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2909218.000000 0.000000 FOR 2909218.000000 FOR S000002922 Structure Therapeutics Inc. 86366E106 06/17/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2909218.000000 0.000000 FOR 2909218.000000 FOR S000002922 Structure Therapeutics Inc. 86366E106 06/17/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2909218.000000 0.000000 FOR 2909218.000000 FOR 1 S000002922 Zai Lab Limited KYG9887T1168 06/17/2026 That, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Samantha (Ying) Du DIRECTOR ELECTIONS ISSUER 36431700.000000 0.000000 FOR 36431700.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/17/2026 That, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: John D. Diekman DIRECTOR ELECTIONS ISSUER 36431700.000000 0.000000 FOR 36431700.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/17/2026 That, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Richard Gaynor DIRECTOR ELECTIONS ISSUER 36431700.000000 0.000000 FOR 36431700.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/17/2026 That, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Nisa Leung DIRECTOR ELECTIONS ISSUER 36431700.000000 0.000000 FOR 36431700.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/17/2026 That, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: William Lis DIRECTOR ELECTIONS ISSUER 36431700.000000 0.000000 FOR 36431700.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/17/2026 That, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Scott Morrison DIRECTOR ELECTIONS ISSUER 36431700.000000 0.000000 FOR 36431700.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/17/2026 That, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Leon O. Moulder, Jr. DIRECTOR ELECTIONS ISSUER 36431700.000000 0.000000 FOR 36431700.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/17/2026 That, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Michel Vounatsos DIRECTOR ELECTIONS ISSUER 36431700.000000 0.000000 FOR 36431700.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/17/2026 That, each director nominee identified below is hereby re-elected to serve as a director until the 2027 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Peter Wirth DIRECTOR ELECTIONS ISSUER 36431700.000000 0.000000 FOR 36431700.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/17/2026 That, the appointment of KPMG LLP and KPMG as the Company's independent registered public accounting firms and auditors to audit the Company's consolidated financial statements to be filed with the U.S. Securities and Exchange Commission and The Stock Exchange of Hong Kong Limited for the year ending December 31, 2026, respectively, is hereby approved. AUDIT-RELATED ISSUER 36431700.000000 0.000000 FOR 36431700.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/17/2026 That, the authority of the Board of Directors to fix auditor compensation for 2026, is hereby approved. AUDIT-RELATED ISSUER 36431700.000000 0.000000 FOR 36431700.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/17/2026 That, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved. SECTION 14A SAY-ON-PAY VOTES ISSUER 36431700.000000 0.000000 FOR 36431700.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/17/2026 That, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved. SECTION 14A SAY-ON-PAY VOTES ISSUER 36431700.000000 0.000000 FOR 36431700.000000 FOR 1 S000002922 Zai Lab Limited KYG9887T1168 06/17/2026 That, a general mandate to the Board of Directors to allot and issue ordinary shares and/or ADSs and/or resell treasury shares of up to 10% of the total number of issued ordinary shares of the Company (excluding treasury shares) as of the date of the Annual Meeting until the 2027 annual general meeting of shareholders, is hereby approved. CAPITAL STRUCTURE ISSUER 36431700.000000 0.000000 FOR 36431700.000000 FOR S000002922 Zai Lab Limited KYG9887T1168 06/17/2026 That, a general mandate to repurchase ordinary shares and/or ADSs of up to 10% of the total number of issued ordinary shares of the Company (excluding treasury shares) as of the date of the Annual Meeting until the 2027 annual general meeting of shareholders, is hereby approved. CAPITAL STRUCTURE ISSUER 36431700.000000 0.000000 FOR 36431700.000000 FOR S000002922 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Caren Deardorf DIRECTOR ELECTIONS ISSUER 3494255.000000 0.000000 FOR 3494255.000000 FOR S000002922 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Weston Nichols, Ph.D. DIRECTOR ELECTIONS ISSUER 3494255.000000 0.000000 FOR 3494255.000000 FOR S000002922 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Stephanie S. Okey, M.S. DIRECTOR ELECTIONS ISSUER 3494255.000000 0.000000 FOR 3494255.000000 FOR S000002922 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To ratify the selection of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 3494255.000000 0.000000 FOR 3494255.000000 FOR S000002922 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission SECTION 14A SAY-ON-PAY VOTES ISSUER 3494255.000000 0.000000 FOR 3494255.000000 FOR S000002922 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission SECTION 14A SAY-ON-PAY VOTES ISSUER 3494255.000000 0.000000 FOR 3494255.000000 FOR 1 S000002922 Revolution Medicines, Inc. 76155X100 06/18/2026 Elect Alexis A. Borisy DIRECTOR ELECTIONS ISSUER 1974074.000000 0.000000 FOR 1974074.000000 FOR S000002922 Revolution Medicines, Inc. 76155X100 06/18/2026 Elect Mark A. Goldsmith DIRECTOR ELECTIONS ISSUER 1974074.000000 0.000000 FOR 1974074.000000 FOR S000002922 Revolution Medicines, Inc. 76155X100 06/18/2026 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1974074.000000 0.000000 FOR 1974074.000000 FOR S000002922 Revolution Medicines, Inc. 76155X100 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 1974074.000000 0.000000 FOR 1974074.000000 FOR S000002922 Revolution Medicines, Inc. 76155X100 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 1974074.000000 0.000000 FOR 1974074.000000 FOR 1 S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/22/2026 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 20445366.000000 0.000000 FOR 20445366.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/22/2026 Elect Hiroyuki Okuzawa DIRECTOR ELECTIONS ISSUER 20445366.000000 0.000000 FOR 20445366.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/22/2026 Elect Takashi Matsumoto DIRECTOR ELECTIONS ISSUER 20445366.000000 0.000000 FOR 20445366.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/22/2026 Elect Shizuko Ueno @ Shizuko Urano DIRECTOR ELECTIONS ISSUER 20445366.000000 0.000000 FOR 20445366.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/22/2026 Elect Joseph Kenneth Keller DIRECTOR ELECTIONS ISSUER 20445366.000000 0.000000 FOR 20445366.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/22/2026 Elect Yasuhiro Komatsu DIRECTOR ELECTIONS ISSUER 20445366.000000 0.000000 FOR 20445366.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/22/2026 Elect Takaaki Nishii DIRECTOR ELECTIONS ISSUER 20445366.000000 0.000000 FOR 20445366.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/22/2026 Elect Yo Homma DIRECTOR ELECTIONS ISSUER 20445366.000000 0.000000 FOR 20445366.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/22/2026 Elect Akihiro Watanabe DIRECTOR ELECTIONS ISSUER 20445366.000000 0.000000 FOR 20445366.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/22/2026 Elect Reiko Kinoshita DIRECTOR ELECTIONS ISSUER 20445366.000000 0.000000 FOR 20445366.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/22/2026 Elect Stuart Mackey DIRECTOR ELECTIONS ISSUER 20445366.000000 0.000000 FOR 20445366.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/22/2026 Elect Takashi Murata CORPORATE GOVERNANCE ISSUER 20445366.000000 0.000000 FOR 20445366.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/22/2026 Elect Sayuri Tago CORPORATE GOVERNANCE ISSUER 20445366.000000 0.000000 FOR 20445366.000000 FOR S000002922 DAIICHI SANKYO COMPANY, LIMITED JP3475350009 06/22/2026 Amendment to the Equity Compensation Plan COMPENSATION ISSUER 20445366.000000 0.000000 FOR 20445366.000000 FOR S000002922 Kymera Therapeutics, Inc. 501575104 06/24/2026 Elect Bruce Booth DIRECTOR ELECTIONS ISSUER 1796469.000000 0.000000 FOR 1796469.000000 FOR S000002922 Kymera Therapeutics, Inc. 501575104 06/24/2026 Elect Nello Mainolfi DIRECTOR ELECTIONS ISSUER 1796469.000000 0.000000 FOR 1796469.000000 FOR S000002922 Kymera Therapeutics, Inc. 501575104 06/24/2026 Elect John M. Maraganore DIRECTOR ELECTIONS ISSUER 1796469.000000 0.000000 FOR 1796469.000000 FOR S000002922 Kymera Therapeutics, Inc. 501575104 06/24/2026 Elect Elena Ridloff DIRECTOR ELECTIONS ISSUER 1796469.000000 0.000000 FOR 1796469.000000 FOR S000002922 Kymera Therapeutics, Inc. 501575104 06/24/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 1796469.000000 0.000000 FOR 1796469.000000 FOR S000002922 Kymera Therapeutics, Inc. 501575104 06/24/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 1796469.000000 0.000000 FOR 1796469.000000 FOR 1 S000002922 Kymera Therapeutics, Inc. 501575104 06/24/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1796469.000000 0.000000 FOR 1796469.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Proposal to adopt the Annual Accounts for the year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Proposal to cast a favorable non-binding advisory vote in respect of the Remuneration Report 2025. COMPENSATION ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Proposal to approve the proposed dividend for 2026. CAPITAL STRUCTURE ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Proposal to discharge from liability the Managing Directors for the performance of their duties during 2025. CORPORATE GOVERNANCE ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Proposal to discharge from liability the Supervisory Directors for the performance of their duties during 2025. CORPORATE GOVERNANCE ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Dr. Toralf Haag DIRECTOR ELECTIONS ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Mr. Bert van Meurs DIRECTOR ELECTIONS ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Mr. Robert McMahon DIRECTOR ELECTIONS ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Ms. Eva van Pelt DIRECTOR ELECTIONS ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Dr. Eva Pisa DIRECTOR ELECTIONS ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Mr. Stephen H. Rusckowski DIRECTOR ELECTIONS ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Mr. Mark P. Stevenson DIRECTOR ELECTIONS ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027: Ms. Elizabeth E. Tallett DIRECTOR ELECTIONS ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Reappointment of the Managing Directors for a term running up to and including the date of the Annual General Meeting in 2027: Mr. Thierry Bernard DIRECTOR ELECTIONS ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Reappointment of the Managing Directors for a term running up to and including the date of the Annual General Meeting in 2027: Mr. Roland Sackers DIRECTOR ELECTIONS ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Proposal to adopt an amendment to the Managing Board Remuneration Policy. COMPENSATION ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Proposal to reappoint EY Accountants B.V. as auditor for the year ending December 31, 2026. AUDIT-RELATED ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Proposal to reappoint EY Accountants B.V. as the assurance provider for the year ending December 31, 2026. AUDIT-RELATED ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Proposal to authorize the Supervisory Board, until December 24, 2027 to: issue a number of ordinary shares and financing preference shares and grant rights to subscribe for such shares of up to 10% of the aggregate par value of all shares issued and outstanding. CAPITAL STRUCTURE ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Proposal to authorize the Supervisory Board, until December 24, 2027 to: restrict or exclude the pre-emptive rights with respect to issuing ordinary shares or granting subscription rights of up to 10% of the aggregate par value of all shares issued and outstanding. CAPITAL STRUCTURE ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Proposal to authorize the Managing Board, until December 24, 2027, to acquire shares in the Company's own share capital. CAPITAL STRUCTURE ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Proposal to approve discretionary rights for the Managing Board to implement a capital repayment by means of a synthetic share repurchase. CAPITAL STRUCTURE ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 QIAGEN N.V. N72482156 06/24/2026 Proposal to approve the cancellation of whole and/or fractional ordinary shares held by the Company. CAPITAL STRUCTURE ISSUER 6514443.000000 0.000000 FOR 6514443.000000 FOR S000002922 Shionogi & Co., Ltd. JP3347200002 06/24/2026 Allocation of Profits/Dividends CAPITAL STRUCTURE ISSUER 20439649.000000 0.000000 FOR 20439649.000000 FOR S000002922 Shionogi & Co., Ltd. JP3347200002 06/24/2026 Elect Isao Teshirogi DIRECTOR ELECTIONS ISSUER 20439649.000000 0.000000 FOR 20439649.000000 FOR S000002922 Shionogi & Co., Ltd. JP3347200002 06/24/2026 Elect John Keller DIRECTOR ELECTIONS ISSUER 20439649.000000 0.000000 FOR 20439649.000000 FOR S000002922 Shionogi & Co., Ltd. JP3347200002 06/24/2026 Elect Keiichi Ando DIRECTOR ELECTIONS ISSUER 20439649.000000 0.000000 FOR 20439649.000000 FOR S000002922 Shionogi & Co., Ltd. JP3347200002 06/24/2026 Elect Hiroshi Ozaki DIRECTOR ELECTIONS ISSUER 20439649.000000 0.000000 FOR 20439649.000000 FOR S000002922 Shionogi & Co., Ltd. JP3347200002 06/24/2026 Elect Takaoki Fujiwara DIRECTOR ELECTIONS ISSUER 20439649.000000 0.000000 FOR 20439649.000000 FOR S000002922 Shionogi & Co., Ltd. JP3347200002 06/24/2026 Elect Kyoko Hirose DIRECTOR ELECTIONS ISSUER 20439649.000000 0.000000 FOR 20439649.000000 FOR S000002922 Shionogi & Co., Ltd. JP3347200002 06/24/2026 Elect Keiichi Yoshii DIRECTOR ELECTIONS ISSUER 20439649.000000 0.000000 FOR 20439649.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Harry H. Penner, Jr. DIRECTOR ELECTIONS ISSUER 4279485.000000 0.000000 FOR 4279485.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Anthony S. Marucci DIRECTOR ELECTIONS ISSUER 4279485.000000 0.000000 FOR 4279485.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Keith L. Brownlie DIRECTOR ELECTIONS ISSUER 4279485.000000 0.000000 FOR 4279485.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 4279485.000000 0.000000 FOR 4279485.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Herbert J. Conrad DIRECTOR ELECTIONS ISSUER 4279485.000000 0.000000 FOR 4279485.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Rita I. Jain, M.D. DIRECTOR ELECTIONS ISSUER 4279485.000000 0.000000 FOR 4279485.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: James J. Marino DIRECTOR ELECTIONS ISSUER 4279485.000000 0.000000 FOR 4279485.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Garry A. Neil, M.D. DIRECTOR ELECTIONS ISSUER 4279485.000000 0.000000 FOR 4279485.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Denice Torres DIRECTOR ELECTIONS ISSUER 4279485.000000 0.000000 FOR 4279485.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/25/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 4279485.000000 0.000000 FOR 4279485.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/25/2026 To approve an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,400,000 shares to 12,900,000 shares and a clarification regarding the tax withholding provisions applicable to awards under the 2021 Incentive Plan. COMPENSATION ISSUER 4279485.000000 0.000000 FOR 4279485.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/25/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4279485.000000 0.000000 FOR 4279485.000000 FOR S000002922 Celldex Therapeutics, Inc. 15117B202 06/25/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4279485.000000 0.000000 FOR 4279485.000000 FOR 1 S000002922 Duality Biotherapeutics Inc. KYG2929M1087 06/26/2026 Accounts and Reports CORPORATE GOVERNANCE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 06/26/2026 Elect HUA Haiqing DIRECTOR ELECTIONS ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 06/26/2026 Elect CAI Zhiyang DIRECTOR ELECTIONS ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 06/26/2026 Elect XIE Dong DIRECTOR ELECTIONS ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 06/26/2026 Elect CHUAI Shuyin DIRECTOR ELECTIONS ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 06/26/2026 Directors' Fees COMPENSATION ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 06/26/2026 Appointment of Auditor and Authority to Set Fees AUDIT-RELATED ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 06/26/2026 Authority to Repurchase Shares CAPITAL STRUCTURE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 06/26/2026 Authority to Issue Shares w/o Preemptive Rights CAPITAL STRUCTURE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 Duality Biotherapeutics Inc. KYG2929M1087 06/26/2026 Authority to Issue Repurchased Shares CAPITAL STRUCTURE ISSUER 2771377.000000 0.000000 FOR 2771377.000000 FOR S000002922 M3, Inc. JP3435750009 06/26/2026 Elect Itaru Tanimura DIRECTOR ELECTIONS ISSUER 9451653.000000 0.000000 FOR 9451653.000000 FOR S000002922 M3, Inc. JP3435750009 06/26/2026 Elect Akihiko Tomaru DIRECTOR ELECTIONS ISSUER 9451653.000000 0.000000 FOR 9451653.000000 FOR S000002922 M3, Inc. JP3435750009 06/26/2026 Elect Eiji Tsuchiya DIRECTOR ELECTIONS ISSUER 9451653.000000 0.000000 FOR 9451653.000000 FOR S000002922 M3, Inc. JP3435750009 06/26/2026 Elect Rie Nakamura @ Rie Nishimura DIRECTOR ELECTIONS ISSUER 9451653.000000 0.000000 FOR 9451653.000000 FOR S000002922 M3, Inc. JP3435750009 06/26/2026 Elect Yoshinao Tanaka DIRECTOR ELECTIONS ISSUER 9451653.000000 0.000000 FOR 9451653.000000 FOR S000002922 M3, Inc. JP3435750009 06/26/2026 Elect Satoshi Yamazaki DIRECTOR ELECTIONS ISSUER 9451653.000000 0.000000 FOR 9451653.000000 FOR S000002922 M3, Inc. JP3435750009 06/26/2026 Elect Yusuke Tsugawa DIRECTOR ELECTIONS ISSUER 9451653.000000 0.000000 FOR 9451653.000000 FOR S000002922 M3, Inc. JP3435750009 06/26/2026 Elect Mayuka Yamazaki @ Mayuka Onishi DIRECTOR ELECTIONS ISSUER 9451653.000000 0.000000 FOR 9451653.000000 FOR S000002922 M3, Inc. JP3435750009 06/26/2026 Elect Takako Ebata DIRECTOR ELECTIONS ISSUER 9451653.000000 0.000000 FOR 9451653.000000 FOR S000002922 M3, Inc. JP3435750009 06/26/2026 Elect Makiko Shinoda DIRECTOR ELECTIONS ISSUER 9451653.000000 0.000000 FOR 9451653.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Christopher Causey DIRECTOR ELECTIONS ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Richard Giltner DIRECTOR ELECTIONS ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Ray Kurzweil DIRECTOR ELECTIONS ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Jan Malcolm DIRECTOR ELECTIONS ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Linda Maxwell DIRECTOR ELECTIONS ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Nilda Mesa DIRECTOR ELECTIONS ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Judy Olian DIRECTOR ELECTIONS ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Christopher Patusky DIRECTOR ELECTIONS ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Martine Rothblatt DIRECTOR ELECTIONS ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Louis Sullivan DIRECTOR ELECTIONS ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Tommy Thompson DIRECTOR ELECTIONS ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Kevin Tracey DIRECTOR ELECTIONS ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR 1 S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan. COMPENSATION ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR S000002922 United Therapeutics Corporation 91307C102 06/26/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 822896.000000 0.000000 FOR 822896.000000 FOR S000002922